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INTRODUCTION

canplement is one of the major innate oonspecific mechanisms for
host defense in serum.

More than a dozen proteins have been isolated

from serum which have a function in either the activation or regula
tion of complement action.

Complement is similar to the coagulation

sequence in that it comprises a number of precursor proenzymes in
plasma that are sequentially cleaved to generate biologically and en
zymatically active proteins.

A variety of agents may activate comple-

ment by either of tv.o pathways, the "classical" or "alternative".

The

classical pathway is activated primarily by antigen-antibody complexes
of at least two IgG and antigen or one IgM and antigen (Figure 1).

The antigen-antibody complex interacts with the first component of
canplement, Cl.

Cl is composed of three subunits, Clq, Clr and Cls

held together in a calcium-dependent complex.

The interaction of Clq

with the Fe fragment of the immunoglobulin molecule results in conver
sion of Clr and Cls to active proteolytic enzymes.

Cl cleaves the

fourth and second components of ccmplement, C4 and C2, and in the pre
sence of Mg++ they form the classical pathway =nvertase, C42, whose
next subs trate is C3.

The al ternative pathway is a more primitive

form of recognition of "foreign" materials since it does rot require

the presence of specific antibody.
gram negative bacterial endotoxin,

It is activated by such things as
inulin, or zymosan (Figure 2).

C3

or C3b, which is the initial cleavage product of C3; interacts with
factor B in the presence of Mg++ and the enzyme factor D to form the

2

Figure 1.

Activation and regulation of the classical pathway of

CXII!Plement.
erythrocytes.

E are sheep erythrocytes.

A is antibody to sheep
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Figure 2.
carrplement.

Activation and regulation of the alternative pathway of
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alternative pathway oonvertase, C3bBb, whose substrate is additional

C3, thus forming a :pOsitive amplification loop.

The association of

C3b with either the classical or alternative pathway oonvertases al
lows them to use CS

as

a substrate.

Cleavage of

CS may lead to assem

bly of a complex of the terminal complement components, CSb, C6, C7,

C8 and C9.

Attachment of

CSb-C9 to the membrane of the target leads

to lysis by channel formation and subsequent ion loss by the target.
There are three �rtant methods of regulation of. complement
activation in plasma.

First, there are circulating inhibitors of in

dividual complement components, such

as

Cl Inhibitor, which irrever

si bly inactivates Cl by binding as a false substrate (1,
Inactivator, or factor I, which cleaves C3b

and C4b

so

2),

and C3b

that they no

longer function in the classical or alternative pathway oonvertases

(3, 4, 5) (Figures 1, 2).

Secondly, there is a natural decay of some

of the enzymes generated during complement activation, through loss of
one

of the t�-.0 proteins which form the oonvertase.

the classical pathway oonvertase,
minutes at 30°C due

For example, C42,

is an enzyme with a half-life of 10

to decay of C2 (6)

•

In a similar manner, factor

B, which is part of the alternative pathway oonvertase, C3bBb, decays
from the oonvertase with a half-life of 4.5 minutes at 30°C

(7).

The

third mechanism by which complement activation is regulated in plasma
involves the action of proteins which either extend or shorten the
half-life of the classical or alternative pathway C3 oonvertases.
There are three proteins in serum which enhance the activity of the
classical or alternative C3 oonvertases.

Properdin or P is a normal

plasma protein consisting of four nonoovalently

bound subunits which

7
slCMs the decay of C3bBb (8)

•

C3 nephritic factor, or C3 NeF, is an

autoantibody found in serum from
erative glomerulonephritis.

same

patients with membranoprolif

C3 NeF reacts with the alternative path

way convertase; it also slCMS the rate of decay of the alternative
pathway convertase (9, 10).

An analogous autoantibody against the

classical pathway C3 convertase which stabilizes the classical C3 con
vertase has also been recently reported in serum from patients with
systemic lupus erythematosus (ll, 12).

Conversely, there are two pro

teins in serum which decrease the activity of the classical or alter
native C3 convertases.

C4 binding protein, or C4bp, acts as a cofac

tor for factor I in the cleavage of hemolytically active C4b to inac
tive C4bi, as well as causing accelerated decay of C2 from EAC42 (13,
14)

(Figure 1).

SlH, or factor H, analogously, acts as a cofactor for

factor I in the cleavage of hemolytically active C3b to inactive C3bi,
as well as causing accelerated decay of factor B from EAC3bBb (15, 16)
(Figure 2).
Although lysis of the target is possible via the terminal comple
ment sequence, the central biologic impact of complement activation
takes place with C3.

A more detailed examination of C3 is therefore

Intially, cleavage of C3 was thought to take place in

warranted.
three steps.

First, either the classical (Cl42) or alternative

(C3bBb) pathway convertase cleaves C3 into two fragments, C3b, which
has a molecular weight of 171,000 daltons, and C3a, which has a molec
ular weight of 8,900 daltons (Figure 3).
ity (17).

C3a has anaphlytoxin activ

C3b, once formed, has a transient ability to react with

cell surfaces, soluble proteins, etc; inactivation of that reactive

8

Figure 3.
convertase.

Cleavage of C3 by classical or alternative pathway C3
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10
site is the result of reaction with water (18, 19).

A covalent ester

bond is fonned between C3b and a surface (18, 19): C3b on the surface

then functions in either the classieal or alternative pathway conver
tases.

Loss of C3b activity in either convertase was intially as

cribed to C3b inactivator, rt::M krt:Mn as factor I, which was thought to
cleave C3b into tw:> fragments, C3c and C3d (4, 20).

Neither fragment

could participate in further C3 cleavage or cleavage of CS, the next
cxrnponent of the canplement cascade, therefore halting the canplement
sequence at that point.

Later a cofactor for factor I was described

by Whaley and Ruddy (16) \\tlich was recognized as a previously isolated
serum protein of unkrt:Mn function, GlH.

SlH, rt::M called factor H,

functions in two ways to regulate the alternative pathway.

As men

tioned above, factor H causes accelerated decay of factor B from the
alternative pathway convertase EAC3bBb (16); it also potentiates the
activity of factor I in cleaving C3b bound to cells by either the al
ternative or classical pathway (15).

Factor H is absolutely required

for cleavage of fluid-phase C3b by factor I (21).

The effectiveness

of factor H on the alternative pathway C3 convertase is a critical
component in distinguishing surfaces which support the alternative
pathway.

Sheep erythrocytes ordinarily do not activate the alterna

tive pathway.

However, treatment of sheep erythrocytes with neuramin

idase generates cells which are then able to activate the alternative
pathway convertase (22, 23, 24).

The C3b on neuraminidase treated

sheep erythrocytes no longer interacts effectively with factor H; thus
the feedback loop illustrated in Figure 2 is operative.

This accounts

at least in part for the "nonspecificity" of alternative pathway
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act;i vation, in that the surface of the particle in

some

manner oon

trols the accessibility of C3b to factor H and subsequent alternative
pathway activation.
Mbce recently, another intermediate in C3 cleavage has bee n de
tected.

Factors I and H are

'flOII

k'flOIIn to result in an intermediate,

C3bi, in which two peptide bonds of the
(Figure 4).

<l

chain has been cleaved

Another enzyme such as trypsin, plasmin or elastase then

cleaves C3bi into the previously recognized fragments C3c and C3d (25,
26).
Receptors for C3 and its cleavage products have been recognized
for nearly 30 years.

In 1953, Nelson described a receptor on human

erythrocytes for the initial cleavage product of C3 (27).

This recep

tor for C3b is responsible for the phenomenon known as immune adher
ence and is present on primate erythrocytes and nonprimate platelets.
Subsequently, receptors for C3b were described on a number of .other
cell types (Table 1).

!Ulynorphonuclear leukocytes (PMN)

(28), B

lymphocytes, macrophages (29) and monocytes (30) were all found to
have C3b receptors.

Visceral epithelial cells of the renal glomerulus

(31), and mast cells (32) were most recently found to bear C3b recep
tors.

C4b can also serve as a ligand for the C3b receptor on several

of these cells, including human erythrocytes (33) as well as B lymph
ocytes, granulocytes and monocytes (34).

Same B lymphocytes also bear

receptors for the final cleavage product of C3, which is C3d (35).
Upon recognition of the C3bi step, the cell types previously thought
to bear C3b and/or C3d receptors, such as B lymphocytes, have. been
reexamined for receptors for C3bi and/or C3d.

CUrrently,

some

B
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Figure 4.

Cleavage of C3b following treabnent with factors H,

and/or protease.

I,
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TABLE 1
P RESENCE OF COMPLEMENT RECEPTORS ON SELECTED HUMAN CELL TYPES

CELL TYPE

C3b

C3bi

C3d

C4b

Erythrocyte

+, 27

-, 36

-, 36

+, 33

ND

B lymphocyte

+, 29

+, 36,37

+, 36,37

+, 35

41

Monocyte

+, 30

+, 36,37

+, 34

NO

Neutrophi1

+, 28

+, 36,37

-, 36,37

+, 34

NO

Glomerular
Epithelial Cell

+, 31

+, 36

-, 36

ND

ND

Mast ce 11*

+, 32

+, 44

-, 44

ND

ND

Raji cell

-, 37

+, 44

+, 44

ND

=

not done.

-, 37

-, 44

factor H

NO

* Studies available only i n rats.

..,.,
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lyrrg;tlocytes are thought to bear C3b, C3bi and C3d receptors, while
m:>nocytes, EMNs arrl glanerular epithelial cells have only C3b and C3bi
receptors (36, 37).
In addition to these oorrnal cells, a number of lymphoblastoid
cell lines have receptors for the various forms of C3.

A receptor for

C3 and its cleavage products on Raji cells, a line orignally derived
fran a Burkitt's lymphana in 1965

(38), was first described by Theo

filopolous, Bokisch and Dixon (39).

'lbese receptors, unlike those

found on normal B lymphocytes, do not interact with C4b (40).

It is

now thought that Raji cells bear two distinct receptors, one for C3bi,
arrl one for C3d.

The variable amounts of C3b resetting observed by

different investigators may be explained by the report that these .
cells and normal B lymphocytes release endogenous factor I when ex
posed to C3b-bear ing cells in the presence of small am::>unts of factor
H, thereby converting C3b to C3bi (41)

•

These

same

workers also pre

sent evidence for a receptor for factor H on Raji cells.

Another pos

sible explanation for variable C3b-dependent rosettes may be found in
the description by Okuda and Tachibana of an alteration in C3b after
treatment with factor H (42).

El:ythrocytes bearing C3b treated with

small am::>unts of factor H are subsequently able to form rosettes with
Raji cells.

Since factor H is a ccmnon contaminant of C3 prepara

tions, this could potentially explain the variability seen in C3b
dependent rosettes formed with Raji cells.

A universal biologic role

of receptors for C3b, C3bi or C3d has remained obscure for many years
despite the knowledge of their role on phagocytic cells.
bound C3b prarotes phagocytosis by EMNs,

Particle

(43) mast cells (44), or ac-
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tivated macrophages (45) in the absence of specific antibody.

In cell

types \Jlich do not respond to C3b alone for phagocytosis, addition of
C3b

can

prO!l'Ote ingesticn by nonocytes and oormal macrophages in the

presence of a concentration of IgG which by itself is ineffective

(46).

However, the function of the C3b receptor

en

ronocytes and oor

rnal macrophages which only mediates adherence has been shown to be
modulated in a variety of ways.

In 1975 the original observation was

made that intraperitoneal injection of thioglycollate into mice al
tered the function of· the complement receptor so that both attachment

and phagocytosis occurred.

Later, a lymphokine was described by Grif

fin and Griffin \Jlich affected the function of the complement receptor
on

macrophages in vitro in a similar manner (47).

Other workers sub

sequently found that culture of human peripheral blood monocytes for
seven days in the presence of serum but in the absence of any other
kind of stimulant also led to phagocytosis as well as adherence medi
ated by the oomplement receptor (48).

The mechanism by W!ich the

function of the complement receptor on ronocytes and macrophages is
changed from one of adherence to one of adherence and phagocytosis is
oot clear.

Phagocytosis by these cells might be due to either in

creased numbers of receptors or expression of a d ifferent type of
plement receptor.

com

No evidence to support or refute these possibili

ties has been published.

A third possibility is supported by evidence

presented by Griffin and Mullinax which suggests strongly that altera
tion .in the function of the complement receptor on macrophages is due
to increased receptor robility, rather than increased numbers or dif
ferent types of receptors (49).

They found that macrophages treated
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with lympho kine or macrophages elicited with thioglycollate, both of
which can mediate phagocytosis, localized all of their receptors for
complement to immobilized surfaces bearing complement.

In contrast,

untreated or normal macrophages did not localize their receptors to
these surfaces and retained the ability to form rosettes with eryth
rocytes bearing complement.

Thus, the function of the C3b receptor on

monocytes and macrophages varies with the physiologic state of the
It is consistently expressed but a connection with phagocytosis

cell.
varies.

For all of these cell types,

(i.e. PMNs, monocytes, macro

phages and mast cells), C3b plays a critical role in host defense
against a variety of organisms by mediating increased adherence of
offending organisms to leukocytes and in same cases phagocytosis by
these cells.

The function of the C3b receptor on B lymphocytes has also been
the subject of investigation for several years.

In 1972, Pepys re

ported that mice depleted of C3 by treatment with cobra venom factor

(CVF), showed an impaired inrnune response to the T cell dependent an
tigen, sheep erythrocytes, while their response to a T cell independ
ent antigen, polyvinylpyrrolidone, was unaltered (50).

0JF, the cobra

equivalent of C3b, forms a 0JF-factor B convertase which is very sta
ble, both in intrinsic decay and regulation by the mammalian serum al
ternative pathway proteins, factors I and H.
all available C3 into C3b (51).

Therefore, 0JF'Bb cleaves

Injection of appropriate amounts of

0JF into animals leads to depletion of C3 to less than 5% of normal
levels for several days.

Later, Waldmann and Lachmann found no re

quirement for serum (serving as a source of complement) for in vitro
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antibody formation (52)

•

The addition of human serum depleted of fac

tor I, which contains high levels of C3b, also did not alter in vitro
antibody formation by spleen cells.

Both of these results provide ev

idence that argues against an abrolute requirement for C3 in antibody
formation in vitro.

Waldmann and Lachmann attributed in vitro effects

of CVF on antibody formation to contamination of CVF with phospho
lipase which is also present in cobra venom.

The effects of CVF in

vivo may however, be due to effects of complement depletion on antigen
localization and cyolical peaks of antibody production.

(53, 54)

In

any case, tl1e apparently normal inmunoglobulin levels and antibody re
sponse to specific antigens seen in genetically C3-deficient individ
uals precludes a necessary role for C3 and/or its degradation products
in antibody responses (55).

C3 and/or its fragments may play a regu

latory role in lymphocyte function.

Several reports have found that

fragments of C3, i.e. C3a, C3b, C3c and C3d, inhibited blastogenesis
of lymphocytes in response to specific antigens but had no effect on
_their response to rnitogens (56, 57, 58).

It is not conclusively es

tablished that these effects are mediated through the C3b receptor on
B lynphocytes, since antibody to the C3b receptor has not been tested

for its influence.

In this case, C3 cleavage products appear to play

a negative regulatory role.

Evidence for a positive role includes the

production of a lymphokine by B lymphocytes incubated with C3b.

These

cells produced a monocyte chemotactic factor in the absence of cellu
lar proliferation (59).

Later ��rk by the same group of investigators

showed that C3b was the only fragment of C3 which induced lymphokine

production.

C3a, C3c and C3d failed to induce lymphokine (60).

The
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d:>servation that lymphokine is produced by B lymphocytes which possess
C3b receptors and is not produced by T lymphocytes which do not is
consistent with a role for the C3b receptor in production, but in no
way proves it.
Chemical characterization of the C3b, C3bi or C3d receptors has
thus far been limited.

It has been knCMn for sane time that the C3b

receptor on eryth(ocytes and leukocytes is trypsin sensitive (28,

29).

The importance of disulfide groups for the function of cample-

nent receptors on Raji cells for rosette formation has also been de-
IIOnstrated (61).

However, cnly tv.u instances of solubilization of

membranes leading to a fraction maintaining complement receptor func
tion have been reported.

In 1975, Dierich and Reisfield solublized

isolated membranes from Raji cells with 2 M KBr and found that both
intact membranes and a high salt extract from membranes inhibited C)
dependent rosette formation (62).

Approximately 400 ng/ml of solu

bilized material caused a 50% inhibition of rosettes.

In 1976, Okuda

and Tachibana solubilized human erythrocyte ghosts with Nonidet P-40

(NP-40) and adsorbed solubilized material to C3b-bearing cells (63).
Material which eluted from the C3b-bearing cells could agglutinate C3b
but

�ot C3d bearing cells.

Perhaps due to the relative insensitivity

and semiquantitative nature of both inhibition of rosettes and hemag
glutination as assays,

no

further work on characterization of oample-

nent receptors was published for some time.
During the years when complement receptors were being found on
various cell types, Hoffman (64) observed inhibition of a::rnplement
tivity by solubilized human erythrocyte membranes.

ac

Using the cample--
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rrent technology available at the time, he found that the extract of
erythrocyte membranes accelerated the rate of decay of the C42 conver

tase (65).

In 1979, Fearon described and isolated a glycoprotein

(gp205) (66) with a I!Olecular weight of 205,000 daltons fran hlllla
l n
erythrocyte membranes which accelerated factor B decay from EAC3bBbP
and served as a cofactor for factor I in the cleavage of fluid-phase
C3b.

Antil:xx]y to gp205 was later shown to blcx::k formation of rosettes

b etween EX::Jb and hlllllan erythrocytes, ruNs, B lymphocytes and monocytes
Fran this it was inferred that gp205 is the C3b receptor.

(67).

Fearon also demonstrated that anti-gp205 precipitated similar molecular weight glycoproteins from all of these cell types.

Other investi

gators have confirmed Fearon's finding that anti-gp205 blcx::ks C3b
dependent rosette·formation (37).

The separate identity of the C3bi

and C3d receptors was then much easier to demonstrate utilizing antigp205.

Dobson et al found that anti-gp205 was unable to blcx::k

com

pletely rosetting due to C3bi and C3d on B lymphocytes, monocytes,
PMNs and Raji cells.
Another approach to the C3b receptor was used by Gerdes, Klatt,
and Stein (68).

High salt extracts fran tonsil cells similar to those

prep�ed from Raji cells by Dierich and Reisfield were adsorbed onto
rabbit C3b-coated sheep erythrocytes and used to inmunize rabbits.
After extensive adsorptions, their antiserll!ll retained the ability to
blcx::k C3b-and C3d-dependent rosette formation.

Immunoprecipitates

fran both tonsil cells and erythrocytes yielded three peaks with ap
6
parent molecular weights of greater than 1 x 10 , 80,000 and 60,000
daltons.

Upon reduction two new peaks of 38,000 and 18,000 daltons
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were observed (69, 70)

The discrepancy between their early results

an1 those of other investigators was reoolved in a recent report in
which another method of membrane isolation yielded a 205,000 dalton
immunoprecipitate similar to gp205 (71).

The relation of the 205,000

dalton immunoprecipitate to their earlier smaller fragments was not
completely clear, although proteolysis was implicated.
After the initial description of gp205 and its influence on the
alternative pathway, work on its other effects has been undertaken.
Since C3b receptors· also bind C4b, Iiada and Nussenzweig isolated
gp205 and tested it for its effects on C4b (72).

TWenty percent of

labeled gp205 bound to EI\Cl4 whereas only 3% bound to Wlel alone.
Additi onally, uptake of labeled gp205 on WIC14 could be lowered by
increased anounts of C2.

However, gp205 had no effect on WIC14 bear

ing limited anounts of C4 in the presence of excess C2.

Therefore,

gp205 functions in the classical pathway by competing with C2 for
binding to C4b.

Gp 205 also serves as a cofactor for factor I in the

cleavage of fluid-phase C4b, as does C4-binding protein, a factor
analogous to factor H of the alternative pathway.

Gigli and Fearon

have independently confirmed these results (73).
The function bf gp205 on cell surfaces has also been the subject
of recent investigations.

Obviously, a membrane receptor for C3b

which also has the capacity to avoid the potential biological hazard
of host cell surface oamplement activation by accelerating the decay
of the classical and/or alternative C3 convertases would be of great
value.

Another function of gp205 has been recently deiJPnstrated in

which gp205 mediates adsorptive endocytosis, much like the low density
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Fearon, Kaneko and 'lbomson found that

lipoprotein receptor (74).
anti-gp205 (Fab')

2

but not

(Fab') as well as the labeled ligand,

C3b-OR (C3b covalently attached to sheep erythrocytes) were inter
nalized by PMNs at 37 C

(75)

•

This mechanism could be very important

in clearance of imnune cx::mplexes bearing C3b.

C3b receptors on macro

phages were found to be important in clearance of immune complexes
bearing cx::mplement in v itro.

Trypsin treabnent of macrophages, which

eliminates the cell surface C3b receptor, resulted in lower amounts of
clearance by macrophages (76).
Only one report of isolation and characterization of the C3d
receptor has been published (77).

A glycoprotein of 72,000 daltons

isolated from 15 liters of spent Raji cell media has specific binding
to C3d and not C3b.

(Fab') antibody to this glycoprotein bound
2

cnly to B lymphocytes and not to T lymphocytes, monocytes or PMNs.
The antibody also blocked 100% of C3d-dependent rosettes on B lympho
cytes, Raji cells or Daudi cells, whereas it only blocked 50% of ro
settes formed with C3bi-coated ce:p.s.

The residual 50% binding in the

presence of this antibody is presumably due to a separate membrane
component specific for C3bi, which does not recognize C3d.
In order to determine whether diverse cell types expressed simi
lar components which regulated complement function, a horrogenous cell

line bearing cx::mplement receptors, Raji ceils, was examined for the
presence of activity resembling gp205 and other control proteins on
the alternative pathway.

For cx::mp arison purposes, mononuclear cells

from tonsils were used as a source of gp205.

TWo sources of Raji

cells did bear a membrane cx::mponent which inhibited alternative

23
pathway lysis and caused accelerated decay of �43bBb.

Some inhibi

tion of alternative lysis and accelerated decay of. the alternative
pathway convertase by membrane components of Raji cells was clearly
due to a component d istinct from gp205, whereas inhibition by membrane
components prepared from tonsil cells was entirely due to gp205.
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MATERIAlS liND MEJ.'HODS

Reagents and Buffers

All reagents and buffers and their sources are found in the Ap
pendices.

Any chemical used whose source is not listed was obtained

from Fisher Scientific, Pittsburgh, Pa.
Cellular Intermediates
Sheep erthrocytes (E) were collected in Alsever 's solution and used
after 1 week at 4°C;

E were diluted in gelatin veronal buffer with

0.01 M disodium ethylenediamine tetraacetate (0.01 M �/GVB) and
centrifuged at 800 x G for 5 minutes, after which the supernate was
renoved.

These two steps were repeated until

present in the supernate.

oo

!lPre henolysis was

E were then resuspended in 0.01 M EDTA/GVB

at 1 x 109/ml and incubated at 37"c.

An equal volume of rabbit

antiserum containing IgG antibody to sheep E diluted 1:175 or 1:200 in

0.01 M �/GVB was added dropwise.

Greater concentrations o f

antiserum resulted i n irreversible agglutination o f erythrocytes.
After 1/2 hour at 37°C, erythrocytes with antibody,

(�),were cen

trifuged at 800 x G for 5 minutes, washed once with veronal buffered
saline with gelatin (GVB++) and used for all subsequent steps.

All

further cellular intermediates except EAC43 were generated using vero

na! buffered saline with gelatin and dextrose (DGVB++).
EAC43 were prepared using a serum reagent, R3, depleted of late
complement components as described by Lachmann and Hobart (78).

R3 is

a serum treated with zymosan which depletes it of approximately 50% of
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C3 and sufficient C5 to prevent terminal pathway lysis.

R3 was pre

pared by incubating nonnal human serum at 37°C for 30 minutes with
0. 75 mg/ml of zyrrosan.

After centifugaticn at 800 x G for 5 minutes,
8
FA at 2 x 10 /ml in

serum was rerrov ed and used to generate EIIC4 3.

veronal buffered saline with gelatin (GVB++) were reacted for 2
minutes at 37°C with a 1:10 to 1:60 d ilution of R3 reagent.

Varying

concentrations of R3 were used for irrlividual preparations of EIIC 4 3
deperrli ng on the amount of residual C5 present.

Suramin sodium, an

inhibitor of factor I, was added to a final concentration of 1 mg/ml

and incubated with the erythrocytes for an additional 2 minutes at 37°
c.

Cold gelatin veronal buffered saline with 0.04 M EDTA (0.04 M

ID'ffi/GVB) was added and EI\Cl423 were centrifuged and washed once.
Residual Cl was rerroved and C2 was decayed from the EIIC43 by incuba
tion in 0.04 M ID'ffi/GVB at 37°C for 2 hours.

The resultant EIIC4 3

lysed in the presence of factors B and D and a source of terminal com
plement canponents.
EIIC4 were prepared as descri9ed by Borsos (79), frozen in glyc
erol at -70°C (80), and were the gift of Dr. S. RuddY.
thawed in the folla-�ing manner.

EI\C4 were

9
An aliquot of approximately 4 x 10

EI\C4 in 0.8 ml was placed in a 37°C water bath and allowed to thaw.
0.23 ml of 50% dextrose in saline was added dropwise and incubated 5
minutes at 37°C.

11 ml of prewarrned mannitol/qvB++ was then added

dropwise over a 9 minute interval at 37°C, followed by an additional
35 ml. of prewarrned DGVB++ over an ll minute time period.

FAC4 were

then washed with DGVB++ until no hemoglobin was visible in the su
8
pernate and resuspended to 1 x 10 /ml in DGVB++.

They could then
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be used for Cl titrations.
E1\Cl4 were prepared
pig Cl at 400 units/ml.

by mixing equal volumes of EAC4 and guinea
After incubation at 30°C for 15 minutes,

E1\Cl4 were centrifuged, washed, and resuspended at 1 x 108/ml.
These cells could then be used for C2 titrations.

For preparation of

E1\Cl4°xy2, 10,000 units of human C2 in 0.1 ml were oxidized with 0.1

ml of a 1:200 dilution of potassium iodide reagent in 0.1 M phosphate
pH 6.0
C.

(6) for 5 minutes at room temperature and added to EAC14 at 30°

After 15 minutes, EAC14°xy2 were centrifuged, washed and resus

pended at 1 x 108/ml.

xy
2 ug of C3 were added to EAC14° 2 at 30°C

am incubated for 15 minutes followed by one wash.
Generation of Zymosan-c3bBbP
Zymosan

(2 mg/ml) was incubated with normal human serum diluted

1:3 in r:GVB++ for 10 minutes at 37°C.

Zymosan was rerroved

centrifugation and incubated for 2 hours at 37°C in 0.04 M
rerrove Cl, C2 and factor Bb
was

(ZXd2).

placed on 0.5 mg of ZXd2 with

2.25 ug of

125

by
ED�GVB to

Alternative pathway convertase

�e

addition of 10 ng of factor D,

r factor B and 2.5 ug of properdin in 0.5 ml of

�++ during a 30 minute incubation at 30°C.
factor B onto zymosan was 4.5% of input.

The uptake of

125

r

After centrifugation and one

wash in r:GVB++, zymosan was then incubated with either veronal buffered saline (VBS)

or test materials in VBS.

The radioactivity re-

maining on the zyrrosan was used to quantitate decay of factor B in the
presence of various test materials.
Herrolytic Titration of Complement Oomponents

A single damaged site on the membrane of a cell is sufficient for
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lysis, so that for large numbers of cells, the probablity of lysis
follows the Poisson distribution.

This is the theoretical basis for

all complement titrations which are designed such that only one component is in limiting suppl y

and all others required for lysis are

present in at least 100 fold excess.

All lysis above reagent lysis is

therefore due to the quantity of the limiting reagent being tested.
The average number of hemolytic sites per cell is given
ing expression:
lysed, and

z

=

-

ln ( 1

-

by the follow-

y ) where y is the fraction of cells

z is the average number of hellPlytic sites per cell (81).

A value of 1 Z of hellOlytic activity is 63% lysis.

The titer of a

reagent is the reciprocal of the dilution of reagent which results in

63% lysis or 1 z.
The absorbance of hellPglobin in the supernate of each tube at 414

nm was used to quantitate the allPunt of lysis (A
calculations for
lowing controls:
blank

(CB)

z as described above.

All assays included the fol-

100% lysis (cells plus 1.8 ml distilled water), cell

(cells �lith 0.3 ml of 0.04

M ID'm), reagent blank (RB)

(cells with 0.3 ml of rat serum in 0.04

D), and a::uplement color (CC)
0.04 M ED'I2\).

> and used in the
414

Calculations,

M ED'I2\ but no factors B and

(no cells and 0.3 mls of rat serum in
using the controls described above,

the average number of sites per cell used the following formulas:

corrected 100% lysis (calculated)
100% lysis <�14) - ( CC �i4 + CB A414 ).
y

=

experimental lysis (A 414 )
corrected

- ( CC A 414 + CB A 414
100% lysis (calculated)

for
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reagent lysis = RB(A 414 )-( CC A 414 + CB A 414
corrected 100% lysis(calculated)
Z=-ln( l-y)
reagent z = - ln( 1 - reagent lysis
corrected

C orrected

z were then used

z = z - reagent z.

as z recorded.

Inhibition of Alternative Pathway Lysis
In order to detect inhibition

by test materials of lysis of

EAC43bBb, preliminary titrations of factor B were performed

for incH-

vidual preparations of �43 in the presence of excess factor D and
C5-C9.

EAC43(10

7

cells in 0.1 ml of rx;vB++) were iocubated with

amounts of factor B varying from 0.25 ng/ml to 1 ug/ml and 400 ng/ml
of factor D for 15 minutes at 30°C.
0.3

Bu. of rat serum diluted

�43bBb were then incubated with

1:15 in 0.04 M

ED'm/GVB for one hour at 37°

C which was used to supply excess CS-c9(C' .ED':m).
periments, �43 were first incubated

In inhibition ex

at 37°C with 0.1 ml of test

ma

terial containing membrane extract or C3b control proteins in rx;vs++
or DGVB++ alone. After 1 hour, except in time course studies, 400 ng
of factor D and a amount of factor B which resulted

in 40-90% lysis as

determined from preliminary titrations was added in 0.1 ml of

DGVB++.

This arrount of factor B varied

from 1.2 ng/ml to 797 ng/ml

for various preparations of �43 and was presumably due to variation
in the arro unts of C3b an �43 which could function in the alternative
pathway from time to time.
serum in 0.04 M

After 15 minutes at 30°C, 0.3 ml of rat

ErmVGVB was added as described

above(C' .ED':m).

After 1 hour at 37°C, 1.5 ml of 0.15 M NaCl was added

to each tube.
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'lhe tubes were centrifuged and the anount of henolysis determined
spectrophotanetrically at 414
control containing
in:::luded.

nm.

In inhibition experiments, a "solo"

inhibitory material plus factors B and D was

no

Inhibition of herrolysis

was

quantitated by the empirical

.

relationship Z' where Z' = ln ( 1- decimal fraction of inhibition ).
Dilutions of inhibitor were plotted versus Z' and the reciprocal dilu
tion where Z'

=

0.5 was used as the titer of inhibitor.

Hemolytic Synergy Experiments
�4°xy2 prepared as described above were incubated with 2 ug/
ml of C3 which resulted in approximately 50% lysis (limited) in the
presence of excess CS-c9.

�4°xy23 with limited C3 were incubated

for one hour at 37 C with various inhibitors.

0.1 ml of CS at 100

units/ml and 0.1 ml of guinea pig R345 at 1:120 were added for 1 hour
at 37°C.

R345 is a guinea pig serum reagent treated with potassium

thiocy?"ate (KQIS) to deplete it of C3, C4 and CS (82).
Decay of Classical and Alternative Pathway C3 Convertases
Decay of factor B from EAC43bBb was detected using

amounts

of

factor B as given in individual experiments which caused 50-90% lysis
at 0 minutes of decay.

EAC43bBb were centrifuged and resuspended in

test material or VBS which was d iluted in 0.01 M ED'ffi/GVB.
of 10

7

Aliquots

cells·were removed at various intervals and added to 0.3 m1

of rat serum to detect the inhibition of lysis of EAC43bBb.
life of the convertase
log . Z versus time.
10

The half

(t 1/2) was determined graphically by plotting
Decay of C2 was determined using quantities of

C2 resulting in 50-90% lysis at 0 minutes of decay.

Decay of EAC142

in the presence of test material or buffer, detection of lysis using
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rat

sennn,

and t 1/2 determinations were performed exactly as

described for factor B decay.
Generation of C3bi
C3b at 1 mg/ml in verona! buffered saline with 2.5% dextrose

(D\IBS++) was incubated with 1 ug/ml each of factors H and I for 24
hours at 37°C with 0.05 % sodium azide

(83).

It was then adsorbed

with 1 ml of anti-factor H Sepharose at room temperature for 10 mi
The amount of anti-factor H used

·nutes and filtered over glass wool.
adsorbed 10 ug of purified factor H.

By itself, C3bi had

no

influence

on decay of EI\C43bBb.
Affinity Chromatography

One volume of Sepharose Cl-4B was washed three times in distilled
water and resuspended in d istilled water to make a 50% suspension.
cyanogen bromide (0.15 gm/ml of packed Sepharose) was dissolved in an
equal volume of hot d istilled water and added to the Sepharose suspen
sion.

'fue mixture was maintained with stirring between pH 10.5 and ll

with 4 N sodium hydroxide (NaOH).

After the pH

no

longer rapidly

decreased, 30-50 volumes of cold 0.1 M sodium bicarbonate (NaHC0 )
3
pH 8.0 and ice were added and the suspension filtered over a Whatman
number 1 filter.

For small amounts of Sepharose, the suspension was

rapidly centrifuged.

The "activated" Sepharose was then added to one

volume of a protein solution and rocked overnight at 4•c.

Antibody

solutions had been previously dialyzed versus VBS; all other protein
solutions had been dialyzed versus 0.1 M NaHC0
p rotein concentrations were 5-15 mg/ml.

3

pH 8.0.

In general,

The following day, Sepharose

protein was washed three times with 0.1 M NaHC0

3

and resuspended in

31
1 volume of 1.0

M rronoethanolamine pH 8.0 for two hours with rocking
The Sepharose-protein solution was then washed

at roam temperature.

three times with the following:
0.1

M sodium acetate

1.0

0.01

M Tris-HCl

1.0

0.01

M Tris-HCl

0.15

M NaCl at pH 4.0

M NaCl at pH 8.0
M NaCl

0.01

M ED� at pH 8.0

Following these washes, the Sepharose-protein conjugate was washed in
the relevant buffer for its use.

Between 50-90% of the protein solu

tion was routinely bound to the Sepharose-Cl-4B.
Inhibition of Rosettes
Fifty ndcroliters of �43 which bear both C3b and C3bi at 4 x
8
10 /ml in

GVB++ were ndxed with 0.2 ml of _VBS or dilutions of test

material in

VBS and incubated at 37°C for 15 ndnutes.

5
x 10 Raji cells in

Subsequently, 5

GVB++ were added in 0.05 ml and incubated 30

;m_nutes at 37°C followed by an addditional 10 minutes on ice.

Each

suspension was rerroved and 100-200 Raji cells examined microscopically
for rosette formation with �43.

A positive rosette consisted of 3

or rrore sheep cells around a Raji cell.
the Results,

the percent rosettes in

In all experiments given in

VBS alone was between 40 and 45%.

Raii C ells
Raji cells were obtained from
carolina

(Raji

Dr. Chen at the University of North

CN) or fran the American Type CUlture Collection (A'IXX::)

through Dr. Daniel Conrad,

(Raji

OC).

A number of other Raji cell

lines were also used in selected instances

and their sources given in

the Results.

Raji cells were kept in continuous culture in stationary

flasks using

RIMI 1640 supplemented with 5% fetal calf serum (FCS) and
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5% newborn calf serum (NBCS), penicillin at 100 units/ml, streptomycin
at 100 ug/ml and amphotericin B (Fungizone) at 250 ng/ml.

Spinner

5
cultures were established with Raji cells at 1-2 x 10 ;m1 and cul
6
tured for 4-6 days to a final cell density of 1-2 x 10 /ml.
Subculture of Raji DC old Cell Line by Dilution
Raji cells were plated in 96 well Costar plates at an average of
2 cells/well in conditioned medium (CM).
5
of culture of Raji cells at 1 x 10 /ml.
0.22 micron Milipore filter before use.

CM was generated by 24 hours
CM was filtered through a
The Raji cells in plates

were allowed to grow for 2 weeks with additions of CM at 2-3 day intervals.

ll3 of 192 wells (58%) showed growth after 1 week.

20 of

the fastest growing cell lines were expanded in 24 well plates and
eventually used to establish cell lines.
Tonsil Cells
Tonsils were obtained from patients undergoing routine
tonsilectany through Dr. T. Mohanakumar in the Department of Surgery
at the Medical College of _Virginia.

Tonsils were macerated on a metal

screen and small fragments and cells washed through with RPMI 1640.
Large aggregates were alla.-1ed to settle at 1 x G for 5-10 minutes.

35

8
mls of cells at approximately 1 x 10 /ml were layered over 15 mls of
Ficoll-Hypaque and mononuclear cells isolated by density centrifugation (84).

The monolayer was removed and washed three times with RPMI

8
1640 before freezing at -70°C at 2-5 x 10 /ml.
Membrane Preparation
CUltures of spinner flasks of Raji cells containing 1-4 x 10
cells were centrifuged and washed three times in RPMI 1640.

9

Tonsil

33
9
cells were thawed and 1-10 x 10 cells were used to prepare mem
branes.

The cells were lysed using e ither hypotonic lysis (85) or in

the case of frozen cells using nitrogen cavitation

(62).

Briefly,

viable cells were resuspended in 10 mls of IUMI and incubated at 37°C
for 5 minutes.

1.67 ml of 90% ·glycerol

(v/v) in IUMI was added

cells and incubated at 37°C for 5 minutes.

tO

the

'Ibis step was repeated

twice and the final cell suspension in:::ubated for an additional 5 mi
nutes on ice.

c.

It was then centrifuged at 800 x G for 10 minutes at 4°

After renoving the supernate, the cell pellet was disrupted using

a vortex and lysed

11M MgC1

2

by

the addition of 13 mls of 0.01 M Tris-HCl with 1

and 1 mM cac1
at pH 7.4.
2

After an in:::ubation of 5 mi-

nutes on ice the suspension was centrifuged at 800 x G for 10 minutes
at 4°C.

'!be supernate was rem::>ved and an additional 13 mls of Tris

HCl buffer added and incubated with remaining cells for 5 minutes on
ice.

After another centrifugation at 800 x G for 10 minutes, the two

supernates were combined and centrifuged at 3200 x G for 10 minutes to
pellet mitochondria and lysosomes.

The ho!rogenate was removed with a

Pasteur pipette, diluted to 33 mls with.additional Tris-HCl buffer and
placed in a nitrocellulose tube.
layered underneath the homogenate.

5 mls of 38% sucrose was carefully
After centrifugation at 95,000 x G

for 90 minutes at 4°C, the cytosol was removed and about 5 ml of the
interface =ntaining crude rnenbranes was o btained.
pelleted at 180,000 x G for 30 minutes at 4°C.

M=mbranes were

Potassium bromide

(KBr) extraction of isolated membranes was performed with the addition
of 5 ml of 2 M KBr with 0.01 M N-2-hydroxyethylpiperazine N-2-ethane
sulfonic acid (HEPES)

and 1 reM MgC1
at pH 7.4 for 30 minutes at 4°C
2
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en a

rocker.

Insoluble residue was renoved by centrifugation at

lBO,OOO x G for 30 minutes at 4eC.
of 2 M KBr was used for extraction.

In scme experiments less than 5 m1
This was performed in experiments

where more concentrated preparations of inhibitor were required, i.e.
gel filtration and testing of KBr extracts from various cell lines
using less than 1 x 10

9

cells.

In these cases insoluble material'

was renoved by centrifugation at 4B,OOO x G for 1 hour.

For all

experiments except gel filtration, extracts were dialyzed overnight
versus VBS and the resultant insoluble residue dispersed throughout
the solution before use.

Membranes from tonsil cells were prepared in

an analagous fashion except that cells were disrupted with nitrogen
cavitation.

Thawed cells were placed in a nitrogen bcrnb at BOO pounds

per square inch for 20 minutes and the pressure released.

The disrup

ted cells were collected and centrifuged at BOO x G for 10 minutes to
renove intact cells.

Supernate was then centrifuged at 3200 x G for

10 minutes to reoove any remaining intact cells and nuclei.

Membrane

preparation and extraction was then identical to that described above
for Raji cells.

In one experiment, tonsil cell membranes were ex

tracted with 1% Nonidet P-40 (NP-40)

in VBS overnight at 4°C rather

than in the 2 M KBr buffer.
Gel Filtration

A 1 x 60 em column of Sephacryl 200 or 300 was used to estimate
oolecular weight of inhibitory material fran KBr extracts of both Raji
and tonsil cells.

The column was equilibrated in 2 M KBr with 0.01 M

HEPES or in VBS with 0.1% NP-40.

Extract (0.6 ml)

was added and elut

ed fran the column by pumping 2 M KBr with 0.01 M HEPES or VBS with

35

0.1% NP-40 at 1-2 ml/hr.

One ml fractions were =llected.

Protein

concentration was measured by determining optical density at 280

nm

or

by a modified Lowry determination (86) for fractions =ntaining

NP-40.

Fractions in 2 M KBr were dialyzed overnight versus VBS;

fractions in NP-40 were diluted 1:20 in DGVB++ and both tested for
inhibition of alternative pathway lysis.

Standards to calibrate the

=lumns were applied separately in 2· M KBr.
mined by the elution of blue dextran.

Void volume was deter-

Elution profiles of rolecular

weight standards, inmunoglobulin G, chymotrypsinogen, ovalbumin and
ribonuclease, were monitored by absorbance at 280

nm

or by reaction

with specific antisera for goat immunoglobulin or ovalbumin.

Peak

elution of each marker was used determine Kaverage (Kav).
Kav

=

Ve - Vv
Vt- Vv

where Ve is the elution volume of the marker or peak of alternative
pathway inhibition, Vv is the void volume of the =lumn and _vt is the
total bed volume.

Kav for each marker was plotted against the log-

arithm of rolecuar weight and the standard curve computed by linear
regression analysis.

The volume at which maximal inhibition of alter-

native pathway lysis occurred was used to determine Kav for inhibition

and its rolecular weight was determined from the standard curve.
Immunadsorbents and Adsorbtion Experiments
For testing KBr extract from Raji cells, imnunoadsorbent =lumns of
Sepharose Cl-4B beads bearing goat antibody to factor ·H and HSA were
packed in Pasteur pipettes plugged with glass wo:>l (0.5
KBr extract fiom Raji cells

em

x 3.5 em).

(0.4 ml =ntaining 94 ug of protein) or a

36
dilution of purified factor H in

VBS was passed over the column by

and the column was washed with 1 m1 of VBS

gravity

.

1-1.2 m1 of ef

fluent was collected from both columns and tested for residual inhib
itory hemolytic activity

and protein.

All other experiments discussed

utilized packed adsorbents to minimize dilution of extract.
adsorbents of anti-factor I
volume

Imnuno

and anti-HSA were centrifuged and a packed

(0.2 ml.) of Sepharose iocubated with 0.2 ml. of KBr extract from

Raji cells containing

47 ug of protein or a dilution of purified fac

tor I and allowed to react for
shaking.

After an additonal

10 minutes at room temperature with one

10 minutes, the supernate was removed,

filtered over glass wool and again assayed for residual inhibitory ac
tivity and protein.

Similar adsorption experiments were performed

using KBr extract from tonsil cells
tein)

(0.2 ml. containing 28 ug of pro

and 0.2 m1 of packed anti-HSA, factor I or factor H.

Blocking Experiments with Antibodies
In

same experiments KBr extracts from Raji or tonsil cells were

preincubated at

gp205 or IgE.

4°C for 30 minutes alone or with various antibodies to

Anti-IgE was used as a control.

added and they were then centrifuged at

0.4 m1 of VBS was

48,000 x G for 1 hour at 4°C.

lis mentioned earlier in the Materials and Methods, KBr extracts in VBS
have particulate material which is reJIDved

by centrifugation.

Pre

liminary experiments showed that tv.D-thirds of inhibitory material in
KBr extracts was contained in the precipitate and after resuspension
in

VBS retained its activity.

'Itlis procedure was performed at

avoid the influence of serum factor(s)

4°C to

on the capacity of the KBr ex

tract to inhibit alternative pathway lysis as d iscussed in the Results
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or

to prevent adsorptive endocytosis of C3b receptor mediated by

unbound (Fab'l

2

anti-gp205 (75)

by

tion of rosette formation

in those experiments testing inhibi

KBr extracts.

After preincubation at

°
4 C

and centrifugation the supernates were renoved and the pelleted ex
tract fragments resuspended in the original volume of

VBS

.

These con

trol extracts or extracts treated with antibody were then tested for
inhibition of alternative pathway lysis or ability to inhibit forma
tion of rosettes.
Radiolabeling of Factor

B

The following reagents were added in order to a plastic test tube:
1 small stirring bar
79 ug factor

B in 0.2 m1 of VBS

.04 m1 of lactoperoxidase (LID) at 1 rng/ml
100 UCi of Na

.04 m1 of 3%

H202

125

I

diluted 1:1250 in water

The mixture was stirred gently for 5 minutes and unbound iodine separated

by

gel filtration.

The mixture was added to the top of a column

of Sephadex G-25 (0.5 x 31

em) in VBS that had been pretreated with 1

rng of BSA.

m1 were collected and tested for precipi t-

Fractions of 1

ability of counts with trichloroacetic acid
fraction was added to 0.5
in

VBS

.

actiyity in 0.5

culation:

0.5

by

m1 of each

ml of 20% TCA was added and the tubes

G for 5 minutes.

Residual soluble radio-

m1 of supernate was determined.

activity precipitated

0.005

m1 of bovine serum albumin (BSA) at 1· rng/ml

After preoou nting,

were centrifuged at 850 x

(TCA).

20%

The percent of radio-

TCA was determined by the following cal-
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TCA precipitable

=

1 - Soluble counts x. 2

X 100

Precounts

Fraction 4 was 80% TCA precipitable and had a specific activity of 7.5
x 10

4

counts per minute

(CPM)/ug.

Both unlabeled factor B and frac-

tion 4 were tested for activity using EAC43.

On a weight basis frac

tion 4 retained 31% of the hemolytic activity of the unlabeled pro
Uptake of labeled factor B onto EAC43 was 1% in 0.01 M FD'm.

tein.

(mnspecific uptake) and 3.1% in
ml of factor D (specific uptake)

rx;vs* in the presence of 400 ng/
•

SDS-PAGE Analysis of Fluid-Phase C3b
In order to analyze cleavage of C3b
and H, C3b was labeled with

125

by KBr extracts or factors I

I in a procedure identical to that

used for factor B except that insoluble Lro was used.
C3b had a specific activity of 1.14 x 10
ug}

5

cpm/ug.

Radiolabeled

Labeled C3b

(1

was incubated in 0. 04 ml C>f VBS alone or in the presence of var-

ious reagents.

Reagents included KBr extracts from Raji or tonsil

cells, factor I, factor H or combinations of these.

After incubation

at 37°C for the indicated intervals, 0.16 ml of VBS and suramin sodium
at 1 mg/ml were added to prevent further cleavage of C3b and the sarnr
ples were dialyzed overnight versus 0.0625 M Tris-HCl pH 6.8.

Elec-

trophoresis was performed on 10% acrylamide gels using the Laemmli
buffer system
ethaml

(87).

Appr opriate amounts of 20% SDS and 2-mercapto-

(2�) were added to g ive a final sample concentration of 2%

SDS and 5% 2 ME.

Samples were placed in a boiling water bath for 90

seconds and two crystals of sucrose and 0.005 ml of 0.05% bromophenol
blue then added.

Samples were run at 125 volts for approximately 2-3

39

oours.

After renoval of the stacking gel, slabs· were stained for 30

minutes in 0.5% Oocmassie blue with 25% isopropanol and 10% acetic
acid at room temperature.

°
They were then destained at 50-70 C with

10% acetic acid, allowed to cool and stirred overnite.
.

After destain

ing the gel was placed in 1% glycerol in 10% acetic acid for 30 mi
nutes at roam temperature to stabilize it before being dried on a slab
gel dryer for 90 minutes.

Autoradiography was then performed by ex

posing the dried gel to Kodak X-R-5 X-ray film at -70°C overnight and
developed.
Protein Determinations
Protein concentrations were determined using a standard Lowry
procedure
was used

as

as

mcx:lified by Wang and Smith (B5).
the standard.

Bovine serum albumin
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RESULTS

Influence of KBr Extracts fran Raji and 'lbnsil cells on Lysis of EAC43
by factors B, D and C5-c9
In view of Fearon's observations concerning the ability of gp205
to inhibit alternative pathway dependent lysis (66), KBr extract fran
Raji cells was tested for similar activity in the following experi
ment.

Concentrations of extract from 8-128 ug/ml were preincubated

with EAC43 and theh 16 ng/ml of factor B and 400 ng/ml of factor D
were added.

Alternative pathway lysis was determined exactly

scribed in the Materials and Methods by addition of C' EDTA.

as

de

As shown

in Figure 5, KBr extract from Raji cells produced a dose dependent in
'hibition of the lysis of EAC43 with factors B, o, and CS-c9.

At the

concentration of 128 ug/ml the KBr extract yielded a Z' value of 0.90
which corresponds to 60% inhibition of lysis.

Loss of inhibition was

seen when KBr extract from Raji cells was heated for 30 minutes at 56°
C prior to addition to the EAC43.
another experiment.

Similar results were obtained in

In separate experiments, KBr extracts fran tonsil

cells were shown to possess similar activity in alternative pathway
lysis (Figure 6).

As with KBr extract from Raji cells, preincubation

of 8. 75-140 ug/ml of KBr extract from tonsils with EAC43 produced a
dose dependent inhibition of the lysis after addition of 24. 5 ng/ml of

factor B, 400 ng/ml of factor D and C5-c9.

At the concentration of

140 ug/ml the extract yielded a Z' value of 2.8, which corresponds to
94% inhibition of lysis.

Loss of dose dependent inhibition of alter-

41

Figure 5.

Influence of KBr extract from Raji cells on lysis of

EAC43bBb.

Aliquots of KBr extract (128 ug/ml) were incubated for

30 minutes at 0 °C or at 56°C and then diluted and tested for their
inhibition of lysis of EAC43 incubated with 16 ng/ml of factor B
and 40 0 ng/ml of factor D.
lysis.

o---o

0 °C.

Z' is proportional to the inhibition of

e------e

56°C.
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Figure 6.

Influence of KBr extract from tonsil cells

FJIC43bBb.

Aliquots of KBr extract

on

lysis of

(1.87 mg/ml) were incubated for

30 minutes at 0°C or at 60°C and then diluted and tested for their
inhibition of lysis of EAC43 incubated with 24.5 ng/ml of factor B
and 400 ng/ml of factor D. o-o

0°C.

�

60°C.
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native pathway lysis was seen when extract was heated for 30 minutes

°
at 60 C prior to addition to the EAC43.
·in another experiment.

Similar results were obtained

The extent of inhibition of lysis in the pres

ence of KBr extract fran tonsil cells exceeds that seen with KBr ex
tract from Raji cells.

No arrount of KBr extract from Raji cells was

able to cause 94% inhibition of lysis in these experiments or any
others.

This is also illustrated by comparing inhibition of lysis by

both extracts at a concentration of 16 or 16.75 ug/ml

(Figures 5, 6).

KBr extract from tonsil cells continued to inhibit alternative pathway
lysis by 65% while KBr extract fran Raji cells inhibited lysis by 10%.
Qptimal COnditions for Inhibition of Lysis of EAC43
In order to maximize the sensitivity for inhibition of alter
native pathway lysis by KBr extracts, the effects of variations in
time,

temperature, pH and ionic strength during incubation of KBr ex

tract from Raji cells with EAC43 were studied.
was

incubated for 0-90 minutes with EAC43.

10-80 ug of extract

Fbllowing the preincuba

tion, 3.6 ng/ml of factor B and 400 ng/ml of factor D was added and
lysis due to alternative pathway detected as described in Materials
and Methods.

KBr extract from Raji cells produced a time dependent

inhibition of the lysis of EAC43 by factors B, D, and C5-9 as shown in
Figure 7.

No appreciable changes in inhibition were seen after a

preincubation with EAC43 of 60 minutes.

At the two highest concen

trations of extract, inhibition of subsequent lysis was seen with 0

and 15 minutes of preincubation.
Temperature dependence of inhibition of alternative pathway lysis
was also tested as shown in Table 2.

10-80 ug of KBr extract fran

46

Figure 7.

Time dependent influence of KBr extract from Raji cells

on lysis of �43bBb.

Concentrations of KBr extract ranging from

10-80 ug/ml were incubated for varying interals at 37°C with �43
before addition of 3.6 ng/ml of factor B and 400 ng/ml of factor D.

11--11

10 ugjml. D-O 20 ugjml. ______. 40 ug/ml.

o--o

80 ug/ml.
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TABLE 2
INFWENCE OF TEMPERATURE CN INHIBITICN OF ALTERNATIVE
PATHWAY LYSIS BY KBR EXTRJ\CT FROM RAJI CELIS

% Inhibition
Extract ug/ml
Temperature

10

20

40

80

30 c

0*

25

60

44

0 c

47

25

24

38

°
*%of inhibition seen at 37 C with·identica1 concentrations of
extract.
EAC43 were incubated with indicated concentrations
KBr extract at 0, 30 or 37°C for 1 hour prior to addition of
2.5 ng/ml of factor B and 400 ng/ml of factor D.
Inhibition
at 37 C given by Z' units was 1.8, 1.25, 0.82 and 0.63 for
concentrations of 80, 40, 20, and 10 ugjml, respectively.

49
Raji cells was preincubated with EAC43 for 1 hour at 37 c, at 30°C or
at 0°C prior to addition of 2.5 ng/ml of factor B and 400 ng/ml of
factor D.

Residual alternative pathway lysis was detected exactly as

described in Materials and Methods.

32-33% of maximal inhibition seen

at 37°C was retained with preincubation at 30°C or at 0°C when all
concentrations of extract tested were averaged.

For nearly every con

centration of extract tested, preincubation at 37°C was superior and
therefore used for all subsequent experiments.
Effects of varying ionic strengths on alternative pathway inhibi
tion were tested in the following manner.

Ionic strength was varied

using appropriate amounts of GVB++ and 5% dextrose in water

(D5W++) to generate the desired ionic strength.

8-128 ug of KBr

extract from Raji cells in buffers with relative salt concentrations
corresponding to either 0.15 M, 0.075 M or 0.0375 M saline were incu
bated with �43.

After incubation with the extract, 1.2 ng/ml of

factor B and 400 ng/ml of factor D in buffers which restored the rela
tive salt concentration of the cell suspension to 0.075 M saline were
added and subsequent lysis due to the alternative pathway determined
as described in the Materials and Methods.

As shown in Figure 8,

varying the ionic strength during preincubation between EAC43 and KBr
extract from Raji cells did not have a consistent effect on.the amount
of inhibition at all concentrations of extract tested, although an
relative salt concentration of 0.075 M or 0.0375 M appeared to be
somewhat superior to isotonicity.
Finally, the effect of pH during the preincubation between EAC43

and extract was examined.

DGVB++ was adjusted to pH 6.0 or to pH

so

Figure 8.

Effect of ionic strength on capacit y of KBr extract from

Raji cells to inhibit lysis of EAC43bBb.

Concentrations of KBr

extract ranging from 8-128 ug/ml were incub ated for 1 hour at 37°C
in three diff erent ionic strength buff ers with EAC43 before addi
tion of 1.2 ng/ml of factor B and 400 ng/ml of factor D.

Reaction

mixtures were all adjusted to 0.075 M relative salt concentration
when factors B and D were added.

�

0.15 M.

EZa

0.075 M.

D

0.0375 M.
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8.0 with 1 N NaOH or 1 N hydrochloric acid (HCl) for use or used at
its usual pH of 7.3.

8-128 ug of KBr extract fran Raji cells were

tested in IX>VB++ at either pH 6.0 or 7.3

•

After preincubation with

�43, 1.2 ng/ml of factor B and 400 ng/ml of factor D was added in pH
8.0 or 7.3 buffer which returned the pH to 7.3-7.4 during generation
of the alternative pathway convertase.
alternative pathway was determined
Methods and shown in Figure 9.

as

Residual hemolysis due to the
described in the Materials and

No consistent differences in subse

quent lysis of FAC43 was seen when pretreatment by KBr extract was
performed at pH 6.0 or at pH 7 .4.

All subsequent experiments were

performed with an relative salt concentration corresponding to 0.075 M
saline at pH 7.4 for 1 hour at 37°C.
Variability among Raji Cell Lines for Inhibition of Alternative
Pathway Lysis
In early experiments, two separate Raji cell lines, one obtained
fran Dr. Chen

(Raji CN), and the original A'ICC line obtained fran Dr.

Daniel Conrad at the Medical College of Virginia

(Raji DC)

were tested

for their ability to inhibit alternative pathway lysis and found to be
positive.-

Raji CN was kept in continuous passage for over 1 year

while retaining the ability to inhibit the alternative pathway.

KBr

extracts were made at approximately one Jronth intervals during this
time period and were consistently positive for inhibition of alter
native pathway lysis.

Raji DC was also kept in continuous passage the

following year and retained the ability to inhibit the alternative
pathway for 7 Jronths.

Again, KBr extracts were made from this cell

line at approximately one Jronth intervals and were consistently pos-
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Figure 9.

Effect of pH on capacity of KBr extract from Raji cell s

to inhibit lysis of EAC43bBb..

Concentrations of KBr extract rang

ing from 8-128 ug/ml were incubated for 1 hour at 37°C at pH 7.3 or
6.0 with FJ\C43 bef ore addition of 1.2 ng/ml of f actor B and 400
ng/ml of factor D.

Factors B and D were diluted in appropriate

buffers which returned the pH to 7 .4.
�

pH 6.0.

o---o

pH 7 .4.
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itive for inhibition of alternative pathway lysis.

After the indi

cated periods of time in culture, both cell lines on separate occa
sions were found to be negative for inhibition of alternative pathway
lysis.

One of the cell lines, Raji CN, continued to be negative for

at least two separate membrane preparations one month apart.

Aliquots

of one cell line, Raji OC, 1\tlich was frozen at -70°C were thawed, ex
panded and used to reestablish a positive cell line.

Because of the

·apparent variation among Raji cells, three other Raji cell lines were
subsequently obtained, expanded and tested for inhibition of the al
ternative pathway.
(Raji Kumar)

One line was obtained fran Dr. T. Mohanakumar

while another line was obtained fro m Dr. M. Strachan,

(Raji MS), both at the Medical College of Virginia.

An additional

Raji cell line was purchased fro m the American Type CUlture Collection
(Raji AleC).

1-2 x 109 cells from all three sources plus the orig

inal two lines (CN and OC)
extraction.

were used for membrane isolation and KBr

Raji CN old and Raji OC old were the original cell lines

used in initial observations of alternative pathway inhib ition and
were used in all other reported experiments.

Raji CN new and Raji OC

new were passages fran the original cell line which
ited the alternative pathway.

no

longer inhib

In Table 3 the amounts of KBr extract

from various Raji lines and their ability to inhibit alternative path
way lysis is shown.

As extracts became available, the various cell

lines were tested in five separate assays for inhibition of the alter
native pathway and values given are all adjusted for a protein concentration of 1

mg/ml.
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TABLE 3
VARIABILITY IN RAJ! LINES FOR INHIBITION OF
ALTERNATIVE PATHWAY LYSIS

Cell

Line

Inhibition

'

(Z

Raji CN old

5 36

Raji CN new

.07

Raji ATCC

.00

Raji Kumar

.20

Raji MS
Raji DC old
Raji DC new

per mg protein)

•.

•

10

6.10
•

13

Extracts were tested in five hemolytic assays for
inhibition of lysis of EAC43bBb.
All values are adjusted
for an extract concentration of 1 mg/ml.
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Subculture of Raji DC by Dilution
Although the Raji cell lines established through dilution as de
scribed in the Materials and Methods, were certainly not all derived
from single·cell precursors, they were used to investigate the vari
ability of inhibition of the alternative pathway by Raji cell lines.
They were particularly useful in such studies, since their "diver
gence" fran a ·single source occurred at a known time point, rather
than anytime foll<=Ming the original derivation of the Raji cell line
several years ago.

Of the 20 cell lines established through dilution,

three lines, R 1, R 10 and R 18 were selected at random and cultured
in 1-2 liter spinner flasks.

1-2 X 10

9

cells from each cell line

were used for membrane isolation and KBr extraction.

Cell line R ·10

produced a dose dependent inhibition of alternative pathway lysis
(Figure 10).

At 192 ug/ml R 10 caused a 54% inhibition of lysis,

whereas in other experiments R 18 and R 1 showed no inhibition at
similar concentrations.

This result, along with the variability seen

in cell lines obtained from a number of sources, suggests strongly
that all Raji cell lines do not possess a membrane component which
inhibits alternative pathway lysis.
PMSF Sensitivity of Inhibition by KBr Extract from Raji and Tonsil
Cells

Tb test whether a serine protease was involved in inhibition of
the alternative pathway by KBr extracts from either Raji or tonsil
cells, phenylmethylsulfonylfluoride (PMSF)

was added to the extracts

and their residual ability to inhibit the alternative pathway assessed
in two separate experiments.

In the first, 0.5 ml of KBr extract from
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Figure 10.

Influence of KBr extract from Raji cell subline RlO on

lysis of EAC43bBb.

Concentrations of KBr extract ranging from

12-192 ug/ml were incubated for 1 hour at 37°C with EAC43 before
addition of 197 ng/ml of factor B and 400 ng/ml of factor D.
o--o

RlO.
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Raji cells (15-120 ug/ml) was treated either with 1 mM PMSF in isopro
°
EAC43 were added for 1 hour at 37 C,

paml or isopropanol alone.

after which 197 ng/ml of factor B and 400 ng/ml of factor D were
added.

Isoproponal alone had no effect on subsequent lysis with fac

tors B and D and C' EDTA.

Alternative pathway lysis was determin&:l as

described in the Materials and Hethods.

As seen in Figure lla, no

loss of inhibition of the alternative pathway was seen when KBr ex
tract was treated with PMSF; in fact, an increase of about 5-30% at
extract concentrations of 30,

In another

60 and 120 ug was observed.

experiment, 4. 5 to 36 ug of KBr extract from tonsil cells were treated
with isopropanol or PMSF as described.above and incubated with EAC43
°
for 1 hour at 37 C prior to addition of 197 ng/ml of factor B and 400
ng/ml of factor D.

In this case, extract treated with isopropanol

alone had more activity than extract treated with PMSF in isopropanol
(Figure llb).

Some preservation of activity is seen with KBr extracts

fran both cells treated with PMSF.
These two observations prompted use of 1 mM PMSF throughout the
entire membrane isolation procedure of a cell line, Raji NI'CC, which
had failed earlier to inhibit alternative pathway lysis.
tract fran this cell line isolated in the presence of 1

A KBr ex
mM

PMSF did

oot inhibit the alternative pathway as sh<:Mn in Figure 12, though in
the 5ame experiment a KBr extract from tonsil cells did inhibit lys
is.

No serine protease appears to be involved in the inability of

this Raji cell line to inhibit the alternative pathway.
Sensitivity of Alternative Pathwa y Inhibition to Proteoly sis
In order to characterize the nature of the factor(s)

resulting in
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Figure lla.

Influence of 1 rrM PMSF on capacity of KBr extract from

Raji cells to inhibit lysis of �43bBb.

Concentrations of KBr

extract ranging from 15-120 ug/ml wer e incubated as de scr ibed for
Figure 10 with �43 prior to addition of 197 ng/ml of factor B and
400 ng/ml of factor D. 0--0

isopropanol. -----.

isopropanol

with 1 rrM PMSF.
llb.

Infl uence of 1 rrM PMSF on capacity of KBr extract from tonsil

cells to inhibit lysis of �43bBb.

Concen trations of KBr extract

ranging from 45-360 ug/ml were incubated as de scribed for Figure 10
with �43 prior to addition of 197 ng/ml of factor B and 400 ng/ml
of factor D.
PMSF.

o--o isopropanol.

...___. isopropanol with 1 rrM
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1.6

1.4

1.2

1.0

Z'
0.8

0.6

0.4

·0.2

0

15

30

60

Extract ug/ml

120
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1.0

0.8

0.6

z•
0.4

0.2

o·

45

90

180

Extract ug/ml

360
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Figure 12.

Capacity of KBr extract from Raji A'J.'Cl: prepared in the

presence of 1 mM PMSF to inhibit lysis of EAC43bBb.

Concentrations

of KBr extract from Raji A'J.'Cl: ranging from 14-225 ug/ml or KBr
extract from tonsil cells ranging from 4.5-36 ug/ml were incubated
as

described for Figure 10 with EAC43 prior to addition of 47 ng/ml

of factor B and 400 ng/ml of factor D.
Raji cells. o----o

._-.

KBr extract from

KBr extract from tonsil cells.
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inhibition of alternative pathway lysis by KBr extract from Raji

cells, KBr extract was treated with three sources of proteases and
tested for inhibition of alternative pathway lysis.

Three concentra

tions of trypsin (3.3 ug/ml, 33 ug/ml and 333 ug/ml) were used to
treat KBr extract from Raji cells for 30 minutes at 37°C foll�ed by a
four fold excess of soybean trypsin inhibitor prior to addition to
�43.

Control tubes containing KBr extract with the highest concen

tration of SBTI as well as KBr extract alone were also included;
effect of SBTI alone on subsequent lysis was observed.

no

As sho\.m in

Figure 13, increasing amo unts of trypsin had no consistent effect on
inhibition by KBr extract from Raji cells ranging from concentrations
of 16-256 ug/ml.

This observation was somewhat surprising, in view of

the trypsin susceptibility of the C3b receptor on a number of cell
types

(28, 29).

Another approach to this question utilized Sepharose Cl-4B which
had either pronase or protease covalently attached using cyanogen bro
mide as described in the Materials and Methods.

400 ug of KBr extract

fran Raji cells was incubated at 37°C for 1 hour with 0.2 ml of anti
HSA-Sepharose, pronase-Sepharose or protease-Sepharose.
Sepharose conjugates had 1 mg/ml of enzyme attached.

Both enzyme

Supernates were

removed, filtered over glass wool and tested for their ability to in
hibit alternative pathway lysis.

Fbllowing a 1 hour inucbation with

�43, 1 ug/ml of factor B and 400 ng/ml of factor D was added for de
tection of lysis as described in Materials and Methods.
inhibition was seen with either enzyme (Figure 14).

No loss of

The covalently

attached enzymes completely destroyed the hemolytic activity of 20 ug
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Figure 13.

Effect of trypsin treatment on capacity of KBr extract

from Raji ce lls to inhibit lysis of EAC43bBb.

0.05 ml of KBr

extract at 1.3 mg/ml was incubated with concentrations of trypsin
ranging from 0 to 333 ug/ml for 30 minutes at 37°C.

Subsequently,

a four fold excess of soybean trypsin inhibitor was added and ex
tracts tested for inhibition of alte rn ative p athway lysis.

COncen

trations of KBr extract ranging from 16-256 ug/ml were incubated as
described for Figure 10 with EAC43 prior to addition of 39.8 ng/ml
of factor B and 400 ng/ml of factor D.
_______. 256 ug/ml.

o---o 128 ug/ml. Q--0 64 ug/ml.

� 32 ug/ml.

........__.

16 ugjml.
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of factor B in a 1 hour in:::ubation at 37 C.
MOlecular Weight Determinations
KBr extract from Raji cells (0.6 ml)

was analyzed

tion on Sephacryl 300 in 2M KBr with 0.01M HEPES.

by gel filtra

Fractions were

dialyzed and tested for their ability to inhibit the alternative path
way.

Peak inhibition was observed shortly after the void volume of

the column corresponding to an apparent I!Olecular weight of 470,000
daltons (Figure 15).

KBr extract from tonsil cells (0.6 ml)

in 2M

KBr was analyzed in a similar fashico and is shown in the same fig
ure.

Peak activity eluted corresponding to an .apparent I!Olecular

weight of 270,000 daltons.

Extracts of tonsil cell membranes with 1%

NP-40 were also analyzed

by gel filtration using Sephacryl 200 in the

presence of 0.1% NP-40.

Fractions were analyzed for protein by Lowry

determinations and on two occasions for inhibitico of the alternative
pathway.

'lWo separate peaks of activity were detected in both in

stances, corresonding to apparent·molecular weights of 155,000 and
52,000 daltons.
16.

The elution profile of this column is shown in Figure

The d iscrepancy in molecular weight of inhibition of alternative

pathway lysis by tonsil cells extracted in these two manners suggests
that in 2M KBr there remains some aggregation of membrane material.
MOlecular weights of inhibitor(s) of the alternative pathway in 2M
KBr of either KBr extract from Raji or tonsil cells are probably spur
iously high.
Absence of Cross-Reactivity with C3b Control Proteins
Since both Raji cells and B lymphocytes have been rePorted to
synthesize factor I in the presence of factor H (41), KBr extracts
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Figure 15.

Sephacryl 8-300 gel filtration of KBr extracts from

Ra j i and tonsil cells.

The values for Kav derived from elution

volume are plotted against standards of known molecular weight and
the elution positions of each shown.

The values for Kav derived

from peak elution of Z' values reflecting inhibition of alternative
pathway lysis are also shown.
ovalbumin, and IgG.

Standards are chymotrypsinogen,

0.8

0.6
Kav

0.4

0.2

0

25

40

83

100

158

251

398

630

Molecular Weight ( 1 o-3)
'-I
w
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Figure 16.

Sephacryl s-200 gel filtration of 1% NP-40 extract from

tonsil cells.

Cblumn fractions were tested on two separate occa

sions for inhibition of alternative pathway lysis.
tested for protein.
shown.

They were also

Peak elution of molecular weight standards are

Standards are identical to those used in Figure 15 with the

addition of ribonuclease.

�

Z' values from assay 1.

�

Z' values from assay 2.

�

ug/ml protein.
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fran both Raji and tonsil cells were adsorbed with Sepharose-bound
antibodies to factor H, factor I or HSA to determine if inhibition was
due to their content of factors I or H.

Adsorption by Sepharose-bound

anti-factor H did not remove 68% of all alternative pathway inhibition
due to KBr extracts from Raji cells as shown in Table 4 though the
colurm had a capacity of 1. 47 ug of purified factor H.
factor H had a Z' value of approximately 3.

'Ihis amount of

After adsorption with

anti-factor I, KBr extract from Raji cells retained 70% of its ability
to inhibit the alternative pathway, though an equivalent amount of im
munoadsorbent was capable of removing 0.588 ug of partially purified
factor I.

1.

'Ihis amount of factor I yielded a Z' value of approximately

These experiments indicate little if any immunologic cross

reactivity between KBr extract from Raji cells and factors I and H.

An identical experiment utilizing KBr extracts from tonsil cells was
performed using all three antibodies.

Adsorption with any of these

immunoadsorbents failed to remove inhibition of the alternative path
way due to KBr extract as shown in Table 5.

The apparent two fold de

crease in activity per mg of protein seen with anti-HSA reflects small
variation in inhibition which is multiplied in the calculations.
Influence of a Serum Factor(s) on Inhibition of Alternative Pathway
Lysis due to KBr Extract from Raji and 'Ibnsil Cells
In the course of testing monoclonal culture supernates for their
ability to remove inhibition of the alternative pathway by KBr ex
tract?, calf serum was found to contain a factor(s)

which completely

blocked the ability of KBr extract from Raji cells to inhibit the
lysis of EAC43bBb.

Addition of 0.5% FCS and 0.5% NBCS (which had been

77

TABLE 4
IMMUNO ADSORPTION OF KBR EXTRACT FROM RAJ! CELLS WITH
AFFINITY ADSORBENTS FOR HSA, FACTOR H AND FACTOR I.

Experiment

Immunoadsorbent

Activity/mg protein

Anti -HSA

2

118.5 Z'

Anti -factor H*

80.5 Z'

Anti -HSA

44.6 Z'

Anti -factor I**

35.1 Z'

*Column adsorbed 1.47 ug of factor H.
**Adsorbent adsorbed 0.59 ug of factor I.

78

TABLE 5
IMMUNOADSORPTION OF KBR EXTRACT FROM TONSIL CELLS WITH
AFFINITY ADSORBENTS FOR HSA,

Il11llunoadsorbent

FACTOR H AND FACTOR I

Activity/mg protein

Anti-HSA

524.3 Z'

Anti-factor H*

858.9 Z'

Anti -factor I**

*Adsorbent adsorbed 5.1 ug of factor H.
**Adsorbent adsorbed 9.8 ug of factor I.

1054.0 Z'
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incubated at 56°C for 30 minutes prior to use in tissue culture to
eliminate oanplement activity) to KBr extract fran Raji cells com
pletely abolished its effect on the alternative pathway (Figure 17).
Similarly, addition of 0.5% FCS and 0.5% NBCS to KBr extract from ton
sil cells reduced inhibition of the alternative pathway by 50% at 136·
ug/ml of extract, by 90% at 68 ug/ml of extract and completely abol
ished inhibition due to 17 and 34 ug of extract

(Figure 18).

tial characterization of this factor was undertaken.

A par

First, a similar

effect can be denonstrated using human serum as well as calf serum.
Human serum was first incubated at 60°C for 30 minutes to eliminate
inhibition of the alternative pathway due to factor H in serum.
Add ition of 1% normal human serum caused a reduction in inhibition due

to KBr extract fro m Raji cells as denonstrated in Figure 19.

Inhib

ition of the alternative pathway was eliminated at extract concentra-·
tions of 3.75-15 ug/ml and was reduced by 70% at concentrations of 30

and 60 ug/ml.

In additional experiments, the effects of dialysis,

further heat-treatment of calf serum or treatment of calf serum with

lmM PMSF on elimination of inhibition due to KBr extract fran Raji
cells were examined.

As seen in Tables 6 and 7, neither dialysis nor

treatment of calf serum with 1 mM PMSF destroyed the ability calf
serum to block inhibition of alternative pathway lysis by KBr extract
fran Raji cells.

Only additional heating for 1 hour at 60°C reduced

the effects of serum on inhibition of alternative pathway lysis due to
KBr extract fran Raji cells.
Relationship of KBr Extract from Raji or Tbnsil Cells to gp205
Since gp205 is known to inhibit alternative pathway lysis by

80

Figure 17,

Infl uence of calf serum

on

capacity of KBr extract from

Raji cells to inhibit lysis of FAC43bBb.

Concentrations of KBr ex

tract ranging from 7 S UO ug/ml were iocubat ed with FAC43 in the
.

-

presence or absence of 0.5% FCS and 0.5% NBCS as described in Fig
ure 10 prior to addit ion of 197 5 ng/ml of factor B and 400 ng/ml
.•

of factor D.

o---o

IGVB++.

.--e

rx;w++ with FCS and NBCS.

81

0
..,

0
CD

0
..,

II)

II)
..

�

0

CD

CD

..,

..,

0

0

0

0

N

0

U
Cll
...
><
w

82

Figure 18.

Infl uence of calf serum

en

capacity of KBr extract from

tonsil cells to inhibit lysis of EIIC43bBb.

Concentrations of KBr

extract ranging from 17-136 ug/ml were incubated with EIIC43 in the
presence or· absence of 0.5% FCS and 0.5% NBCS as described for Fig
ure 10 prior to additicn of 20 ng/ml of factor B and 400 ng/ml of
factor D.

NBCS

.

o--o

JXNB++

•

.--. IXNB++ with 0.5% FCS and 0.5%
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Figure 19.

Infl uence of human sen.nn on capacity of KBr extract

from Raji cells to inhibit lysis of EAC43bBb.

Concentrations of

KBr extract ranging from 3. 75-60 ug/ml were incubated with EAC43 in
the presence or absence of 1% normal human serum as.described in
Figure 10 prior to addition of 20 ng/ml of Factor B and 400 ng/ml
of factor D.
serum.

0-:--0 J:GVB++. e-----e

J:GVB++ with 1% normal human
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TABLE 6
CHARACTERISTICS OF CALF SERUM INHIB ITOR

Inhibition (Z')
Extract ug/ml
120

60

1.58

1.54

1.00

None

.07

.09

.05

.00

Dialysis

.00

.00

.00

.00

1.41

.52

15

.00

Serum Treatment

No serum

°

60 C 1 hr

15

30

•

•

73

EAC43 were incubated with KBr extract from Raji cells in
DGVB++ in the presence or absence of .5% fetal calf
serum and .5% newborn calf serum. After 1 hour at
37°C, factor B at 197 ng/ml and factor D at 400 ng/ml
were added.
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TABLE 7
TREATMENT OF CALF SERUM WITH PMSF

Inhibition

(Z')

Extract ug/ml
120

60

30

1.00

.76

.40

1.49

1.03

.51

None

.00

.00

.00

PMSF

.00

.00

Serum treatment

No serum
No serum-PMSF

•

15

EAC43 were incubated with KBr extract from Raji cells in
DGVB++ in the presence or absence of .5% FCS and .5% NBCS
which was untreated or treated with 1 mM PMSF.
After 1
hour at 37°C, factor B at 197 ng/ml and factor D at 400
ng/ml were added.
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accelerating decay of factor B from EAC3bBb, the effect of antibody to
gp205 on the activity of KBr extracts fran both Raji and tonsil cells
was of interest.

Affinity-purified anti-gp205 (Fab') ,
2

Dr. Douglas Fearon,

was

a

gift of

used to block inhibition of alternative path

way lysis by KBr extract from both Raji and tonsil cells (Figure 20)

•

Amounts of antibody as lCM as 8 ng/ml ocmpletely removed inhibition of
the alternative pathway due to KBr extract from tonsil cells whereas
only about 40% of inhibtion due to KBr extract fran Raji cells was re
noved by similar arrounts of antibody.

In the same experiment in data

not sh<:Mn, concentrations of anti-gp205 (Fab')

2

as much as forty-

fold higher still resulted in loss of only 40% of inhibition due to
KBr extract from Raji cells.

Affinity purified anti-gp205 by itself

had no effect on inhibition of alternative pathway lysis due to factor
H .
The ability of another source of anti-gp205, a monoclonal anti
body to the C3 receptor, kindly provided by Drs. Gerdes and Stein, was
also tested for its ability to rembve inhibition of the alternative
pathway due to KBr extracts.

'lb eliminate effects of calf serum which

was present in the supernate of the oonoclonal culture both KBr ex
tracts were preincubated with a source of antibody for 30 minutes,
centrifuged at 48,000 x G for 1 hour and resuspended in _VBS .

M:>use

oono:::lonal antibody to IgE obtained fran Dr. Daniel Conrad or anti-c3
receptor were tested for their ability to block inhibition due to KBr
extracts (Figure 21).

At the single dilution of monoclonal supernate

used, anti--<::3 receptor removed inhibition of the alternative pathway
due to KBr extract fran tonsil cells, whereas it had

no

89

Figure 20.

Influence of

(Fab')

2

fraction of rabbit antibody to

gp205 on capacity of KBr extracts from Raji and tonsil cells to
inhibit lysis of EAC43bBb.

·

Extracts or factor H were incubated

with EAC43 in the presence of concentrations of anti-gp205 ranging
from 0-16 ng/ml as described in Figure 10 prior to addition of 790
ng/ml of factor B and 400 ng/ml of f actor D ...--. KBr extract from
•

Raji cells (887.5 ug/ml).D---0 KBr extract from tonsil cells (37.4
ug/ml).

o---o

Factor H (262 ng/ml).
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Figure 21.

Influence of rronoclcnal anti-c3 receptor or anti-IgE on

capacity of KBr ex tracts from Raji and tonsil cells to inhibit lys
is of EAC43bBb.

Monoclonal antibody was incubated with KBr ex

tracts on ice for 30 minutes, centrifuged at 48,000 x G for 1 hour,
and resuspended in VBS .

COncentrations o f KB r extract from Raji

cells ranging from 14-ll2 ug/ml and tonsil cells ranging from 16128 ug/ml were incubated with EAC43 as described for Figure 10
prior to addition of 790 ng/ml of factor B and 400 ng/ml of factor

D.

o--o

KBr extract from Raji cells with anti-IgE

•

...-. KBr

extract from Raji cells with anti-c3 receptor. D---o KBr extract
fran tonsil cells with anti-IgE .__
•

cells with anti-c3 receptor.

KBr extract from tonsil
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effect on that inhibition seen in the presence of KBr extract from
Raji cells.

A control rroncx:lonal anti-IgE had oo effect on the abil

ity of either KBr extract to inhibit the alternative pathway.

The

source of anti-c3 receptor used in Figure 21 was found to block imnune
adherence of human erythrocytes and EAC43

(Figure 22).

Influence of KBr Extracts on Alternative Pathway C3 Convertase
KBr extract from Raji cells

which inhibited alternative pathway

lysis was tested for its ability to potentiate the decay of factor B
from EAC43bBb.

EAC43bBb were prepared using 781 ng/ml of factor B and

400 ng/ml of factor D.

Subsequently, either VBS in 0.01 M EDTA/GVB or

KBr extract in 0.01 M EI:Ym/GVB was added to a pellet of EAC43bBb cells
°

and the mixture incubated at 30 C.
oo

Residual herrolytic sites present

the EAC43bBb after various time intervals up to 30 minutes were de

termined and t 1/2 of the convertase in the presence of buffer or ex
tract calculated.

As can be seen in Table 8, 735 ug of KBr extract

from Raji cells decreased the half-life of the convertase from 5.5 to
2.3 minutes, a decrease of 41%.

KBr extract from Raji cells also po

tentiated factor B decay from properdin-stabilized EAC43bBbP in a dose
dependent manner; however, KBr extracts from Daudi cell membranes did
oot cause accelerated decay of EAC43bBb (Daniel Conrad, personal
cx::mnunication)

•

In parallel experiments, KBr extract from tonsil cells was also
tested for its influence on the alternative pathway convertase (Table
9).

EAC43bBb were prepared with 494 ng/ml of factor B and 400 ng/ml

of factor D.

29 ug of KBr extract from tonsil cells was found to po

tentiate factor B decay from EAC43bBb by 68% causing a reduction in

94

Figure 22.

Effect of !lPl'loclonal antibody on receptor on human eryth

rocytes f or EAC43.

0.025 ul of monoclonal antibody diluted 1:10 was

incubated at 4 C with 0.025 ul of human erythrocytes at 5
foe 1 hour prior to additi on of 0.025 ul of EAC43 at 4
ReM 1.

Anti-c3 receptor.

RaN 2.

Anti-IgE.

RaN 3.
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TABLE 8
INFLUENCE OF KBR EXTRACT FROM RAJ! CELLS
ON DECAY OF EAC43bBb

Fraction

Extract ug/m1

VBS
Raji

t

1/2 (minutes)
5.5

735

2.3

EAC43 were incubated with 781 ng/m1 of factor B and 400
ng/m1 of factor D for 10 minutes at 30°C.
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TABLE 9
I NFLUENCE OF KBR EXTRACT FROM TONSIL CELLS
ON DECAY OF EAC43bBb

Fraction

Extract ug/ml

4.0

VBS
Tonsil

t l/2 (minutes)

29

1.7

EAC43 were incubated with 494 n g/ml of factor B and 400
ng/ml of factor D for 10 minutes at 30°C.

98
half-life of the convertase from 4 minutes to 1.7 minutes.

In other

experiments, the reduction in half-life of alternative pathway con



vertase due to KBr extract from tonsil cells was shown to be dose
dependent.

Tb determine whether the loss of hemolytic activity of EAC43bBb
was in fact due to physical dissociation of factor B from the conver
tase, the follao�ing experiment using radiolabeled factor B on zymosan

was performed.

Zymosan bearing the alternative pathway convertase

generated as described in the Materials and Methods (ZC3bBbP) was pel
leted and 0. 6 mg was resuspended in 0. OS m1 of VBS alone or VBS con
taining 65 ug of KBr extract from Raji cells or 90 ng of factor H.
Replicate samples were prepared for VBS and KBr extract from Raji
cells.

ZynPsan suspensions were then incubated at 30°C for 15 mi

nutes.

Following this incubation, all tubes were centifuged at 850 x

G for 5 minutes and zymosan washed 2 times with r:x:;vB++.

Radioactiv ity

remaining bound to zymosan particles was then counted and % loss of

125r

for each tube determined.

Decay in VBS alone was 19.2% and

19%, while factor H caused a decay of 52�.

Decay in VBS containing 65

ug of KBr extract from Raji cells was 29% and 27 .5%.
to these were found in two other experiments.

Results similar

Tbgether with the hemo

lytic decay of EAC43bBb, these experiments provide suppor t for the no
tion that inhibition of lysis due to KBr extract from Raji ce lls is
due in part to actual loss of factor B from the alternative pathway
convertase,

rather than an "inactivation" of its function while it re

mains present in the convertase.
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Influence of Fluid-Phase C3, C3b and C3bi on Decay of EAC43bBb in the
Presence of KBr Extract from Raji and Tbnsil Cells
Previous experiments (88)

have shown that fluid-phase C3 and C3b

blocked binding of factor H to EAC43bBb.

In order to detect inter

action between C3 or its cleavage products and KBr extracts, decay of
factor B from EAC43bBb was determined in the presence of fluid-phase
C3, C3b and C3bi.
C3b,

It was postulated that specific ligand

(i.e. C3,

or C3bi) would interfere with the ability of KBr extract from

either cell type to cause accel erated decay of factor B from
EAC43bBb.

For testing the effect of C3, EAC43bBb were pre pared with

175 ng/rnl of factor B and 400 ng/rnl of factor D and resuspended in .vss
in 0.01 M ED�/GVB alone or with factor H, KBr extract from Raji
cells,

or KBr extract from tonsil cells.

One set of tubes for each

test material contained 48-780 ug/rnl of fluid-phase C3.

Hemolysis at

0 or 9 minutes was determined as described in Materials and r-�ethods.
As shown in Table 10, the t 1/2 of EAC43bBb in VBS alone was 7.2
minutes and fell to 3.0, 3.0, or 2.4 minutes in the presence of KBr
extract from Raji cells, KBr extract from tonsil cells or factor H,
respectively.

C3 had

no

dose dependent effect on the increased decay

of EAC43bBb due to KBr extract from e ither Raji or tonsil cells, but
it did reverse the increased decay of EAC43bBb due to factor H in a
dose dependent manner.

A decre ase of 70% in half-life of the conver

tase in the presence of factor H was reduced to only 30% with concen
trations of C3 of 390 ug/rnl or greater.
C3b was also tested in similar experiments (Table ll)

•

In pre

liminary experiments, fluid-phase C3b was shown to inhibit accelerated

10 0

TABLE 10
INFLUENCE OF FLUID-PHASE C3 ON DECAY OF EAC43bBb
DUE TO KBR EXTRACT FROM RAJ! OR TONSIL CELLS

t 1/2 (minutes)
Amount of C3 ug/ml
195

98

48

0

NT

NT

NT

NT

7.2

2.7

2.7

2.6

NT

NT

3.0

Tonsil

3.7

3.8

3.6

NT

NT

3.0

Factor H

5.0

4.9

3.0

3.0

2.7

2.4

Fraction

780

390

VBS

NT

Raji

NT
not tested.
Value given is t l/2 of EAC43bBb in minutes.
EAC43 were incubated with 175 ng/ml of factor B and 400
°
ng/ml of factor D for 10 minutes at 30 C.
KBr extract from
Raji ce l ls was used at 201 ug/ml.
KBr extract from tonsil
cells was used at 156 ug/ml.
Factor H was used at 524 ng/ml.
=

·
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TABLE 11
INFLUENCE OF FLUID-PHASE C3b ON DECAY OF EAC43bBb
DUE TO KBR EXTRACTS FROM RAJI AND TONSIL CELLS

t 1/2 (minutes)
Amount of C3b ug/ml
0

Fraction

98

49

24

12

VBS

NT

NT

NT

NT

20.0

Raji

8.0

8.0

8.0

a. 1

6.9

Tonsil

5.5

4.0

3.8

3.3

2.5

NT= not tested.
Values given are t 1/2 of EAC43bBb in
minutes. EAC43 were incubated with 263. ng/ml of
factor B and 400 ng/ml of factor D. KBr extract from Raji
cells was used at 500 ug/ml. KBr extract from tonsil cells
was used at 187 ug/ml.
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decay of EAC43bBb due to factor H.

EAC43bBb were prepared with 263

ng/ml of factor B and 400 ng/ml of factor D.

The factor B preparation

used for this experiment apparently contained anounts of properdin
which stabilized the alternative pathway convertase

so

that a longer

half-life was observed in this case and in several other experiments.
Decay of factor B from EAC43bBb was determined in test materials pre
pared in an identical manner to that used for C3 described above.

One

set of tubes with each KBr extract contained C3b from 12-98 ug/ml.
After 0 or 8 minute� of decay at 30°C, residual EAC43bBb sites were
detected using rat serum as described in Materials and Methods.

In

this experiment, the reduction in half-life from 20 minutes to 2. 5
minutes (87%)

by KBr extract from tonsil cells was lowered to only 5.5

minutes

by 98 ug/ml of C3b.

(62%)

LcMer concentrations of C3b yielded

intermediate values, approaching a half-life seen in the presence of
KBr extract from tonsil cells.

In contrast, the reduction in half

life by KBr extract from Raji cells from 20 minutes to 6.9 minutes
(65%)

was changed to 8.0-8.1 minutes (60%)

ug/ml of C3b.

in the presence of 24-98

Fluid-phase C3b did not have a dose dependent effect on

decay due to KBr extract from Raji cells.

Figure 23 shows another ex

periment using only KBr extract from tonsil cells and presents another
example of the effect of fluid-phase C3b
decay of EAC43bBb due to KBr extract.
as

described above.

(2.5-40 ug/ml)

on accelerated

EAC43bBb were prepared exactly

After 0 or 8 minutes of decay at 30°C, residual

EAC43bBb sites were detected using rat serum as described in the Ma
terials and Methods.

Accelerated decay of EAC43bBb in the presence of

KBr extract from tonsil cells was again shown to be inhibited in a
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Figure 23.

Influence of fluid-phase C3b on capacit y of KBr extract

from tonsil cells to accelerate decay of �43bBb.

KBr extract

(187 ug/ml) was incubated with �43bBb alone or in the presence of
C3b fran 2.5-40 ug/ml.
ED'ffi/ GVB with

no

�43bBb were alro incubated in VBS-0.01 M

KBr extract.

�43bBb were prepared with 263 ng/

m1 of factor B and 400 ng/ml of factor D.
•

0 ug/ml of C3b

"

2.5 ug/ml of C3b.

...

5 ug/ml of C3b

b.

10 ug/ml of C3b.

•

20 ug/ml of C3b

0

40 ug/ml of C3b.

0

VBS-0.01 M ED'ffi/GVB.

•

•

•
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dose-dependent manner by C3b.

In the presence of KBr extract from

tonsil cells and 40 ug/ml of C3b, half-life of the =nvertase was 3.2
times that seen with KBr extract alone.
Since C3bi is reported to be one of the fragments of C3 with
which Raji cells interact, rather than C3b, decay of FAC43bBb in the
presence of KBr extracts from Raji or tonsil cells and C3bi was of
interest.

FAC43bBb were prepared with 153 ng/ml of factor B and 400

ng/ml of factor D.

Decay of factor B in various test materials was

performed' in an identical manner to that described above for C3.
set of tubes for each material contained 109-875 ug/ml of C3bi.

One
Ac

celerated decay of EAC43bBb due to KBr extract from Raji cells was not
affected by soluble C3bi in a dose dependent manner (Table 12)

•

Decay

due to KBr extract from Raji cells was actually faster by 3. 1 minutes
with concentrations of C3bi of 109 ugjml.

Decay due to KBr extract

from tonsil cells was inhibited by all concentrations of C3bi tested,

although this was not dose dependent.

On the other hand, decay of

EAC43bBb in the presece of factor H 1'/aS inhibited by fluid-phase
C3bi.

Factor H alone caused a reduction in half-life from 18.1 mi-

nutes in VBS to 3. 6 minutes (80%).

In the presence of 875 ug of C3bi

and factor H half-life was reduced to 5. 8 minutes (68%).
nounts of C3bi resulted in
tor H alone.

Smaller a-

half-lives approaching that seen with fac

Since this experiment utilized 8 to 9 times more C3bi

than the previous experiments using C3b, the effect of C3bi on decay
due to factor H could conceivably be due to snail amounts of C3b re
maining in the preparation of C3bi.

Although an intact

a'

chain of

the C3bi preparation indicating incomplete cleavage of C3b to C3bi was
not visible on sodium dodecyl sulfate preparative gel electrophoresis
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TABLE 12
I N FLUENCE OF FLUID-PHASE C3bi ON DECAY OF EAC43bBb
DUE TO KB R EXT RACTS FROM RAJ! AND TONSIL CELLS

t 1/2 (minutes)
Amount of C3bi ug/ml
Fraction

875

438

219

109

0

VBS

NT

NT

NT

NT

18.1

Raji

9.5

7.5

7.5

6.9

10.0

Tonsi1

5.0

4.2

4.6

4.6

3.0

Factor H

5.8

5.2

4.9

4.0

3.6

NT
not tested. Values given are t 1/2 of EAC43bBb in
minutes. EAC43 were incubated with 153 ng/ml of
factor B and 400 ng/ml of factor D. KBr extract from
Raji cells was used at 151 ug/ml. KBr extract from
tonsil cells was used at 94 ug/ml. Factor H was used at
262 ng/ml.
=
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(SDS-PAGE) analysis, the persistence of small amounts of C3b cannot be
completely ruled out.

Alternatively, C3bi may retain a binding site

for factor Fi.
Relationship of Alternative Pathway Inhibition due to KBr Extract from
Raji and Tbnsil Cells with gp205
Previously discussed experiments had shown that inhibition of al
ternative pathway lysis by KBr extract from Raji cells could not be
ccmpletely blocked by anti-gp205 (Fab') : whereas inhibition of
2
lysis due to KBr extract from tonsil cells was blocked by anti-gp205.
Since KBr extract from.both Raji and tonsil cells also accelerated de
cay of factor B from EAC43bBb, anti-gp205 (Fab') were tested for
2
their ability to block acceLerated decay due to either KBr extract
(Table 13).

EAC43bBb were prepared with 204 ng/ml of factor B and 400

ng/ml of factor D.

EAC43bBb were then resuspended in VBS with 0.01 M

�/GVB alone or in the presence of KBr extracts or factor H.

Decay

°
for 0 or 9 minutes at 30 C was determined by the addition of rat serum
as described in Materials and Methods for detection of residual
EAC43bBb sites.

Factor H, KBr extract from Raji cells, or KBr extract

from tonsil cells were tested alone or in the presence of 0.63 ug or 5

ug of (Fab')

2

anti-gp205.

Addition of 0.63 ug of anti-gp205 to KBr

extract from tonsil cells increased the half-life of the convertase
from 3.8 to 5.8 minutes.

Addition of 5 ug of anti-gp205 to KBr ex

tract from tonsil cells increased the half-life of the convertase to
·7.6 minutes, which is similar to the value of in VBS of 8.8 minutes.
·

However, the same amounts of anti-gp205 did not cause an increase in
the half-life of the convertase in the presence of KBr extract from
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TABLE 13
INFLUENCE OF ANTI-GP 205 ON DECAY OF EAC43bBb
DUE TO KBR EXTRACTS FROM RAJI OR TONSIL CELLS

t 1/2 (minutes)
Amount of Anti-gp205
Fraction

5.0 ug

0.63 ug

0 ug

VBS

9.2

NT

8.8

Raji

4.0

4.4

5.2

Tonsil

7.6

5;8

3.8

Factor H

4.2

4.6

4.2

NT
not tested.
Values g iven are t l/2 of EAC43bBb in
EAC43 were incubated with 204 ng/ml of
minutes.
KBr extract from Raji
factor B and 400 ng/ml of factor D.
cells was used at 202 ug/ml.
KBr extract from tons il cells
was used at 125 ug/ml.
Factor H was used at 349 ng/ml.
=
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Raji cells, which

by

itself decreased t 1/2 to 5.2 minutes.

In fact,

both concentrations of antibody appeared to decrease the half-life
even further.

Finally, as a control for effects of anti-gp205 on

Ei\C43bBb decay, the same am:mnts of anti-gp205 had no effect on the
decrease in half-life due to factor H.
COmparison of KBr EXtract from Tbnsil Cells with Factor H on
Cell-Bound C3b
Earlier work on factor H had shown a marked synergy with factor I
on cleavage of cell-bound C3b.

Amounts of inhibition observed in the

presence of both factors I and H is about 5 times· that expected if in
hibition were additive· in nature.

KBr extract from Raji cells had

been tested earlier for its ability to serve as a cofactor for factor
I on cell-bound C3b and found not to synergize with factor I (Daniel
Ccnrad, personal <XJII1llunication)

•

KBr extract from tonsil cells was

also tested for its capacity to serve as a cofactor for factor I.
FAC14°xy23 were prepared as described in the Materials and Methods
with an amount of C3 resulting in about 50% lysis.

Cells were incu

bated with concentrations of factor I frOm 12.5 to 100 ng/ml alone or
in the presence of 33 ng/ml of factor H or 2.3 ug/ml of KBr extract
from tonsil cells.
sulted in a Z'

As can be seen in Figure 24,

value of 0.439,

arrounts of factor I which

by

factor H alone re

but cl early synergized with very low

itself caused little inhibition.

extract from tonsil cells alone resul ted in a Z'

KBr

value of 0.735 and

had only an additive effect with identical amounts of factor I.

Thus,

KBr extract from tonsil cells, like KBr extract from Raji cells, does
not act synergistically with factor I on cell-bound C3b to reduce he-
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Figure 24.

Influence of factor H or KBr extract from tonsil cells

on activity of factor I.

Concentrations of factor I ranging from

12.5-100 ug/ml were incubated with EAC14°xy23 alone or in the
presence of KBr extract from tonsil cells (2.3 ug/ml) or factor H
(33 ng/ml).

EAC14°xy23 were then incubated for 1 hour at 37°C

with C5--c9. o--o factor I.
I and tonsil KBr extract.

D----0 factors I and H

•
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mlysis.
COmparison of KBr Extracts from Raji and Tbnsil Cells on Fluid-Phase
C3b
KBr extracts from both Raji and tonsil cells were tested for
their ability to act

a cofactor for factor I in the cleavage of

as

fl uid phase C3b, since factor H has been shown to be an absolute
requirement in this system

(21).

Figure 25 is an SD5-PAGE electro

phoretic analysis of C3b incubated with factor H, factors I and H, KBr
extract fran Raji cells, or KBr extract fran Raji cells and factor I.
Track 1 shows the

a

and 6 chains of C3b incubated with factor H alone

Tracks 2 and 3 demonstrate the results of factors I

for 60 minutes.

and H for 30 and 60 minutes, respectively, and show the expected
cleavage of the

a

chain with the appearance of a new peak of 42,000

daltons consistent with C3bi.

KBr extract from Raji cells incubated

with C3b alone for 60 minutes was without effect by itself as seen in
Track 4.

In the presence of factor I for 30 or 60 minutes in Tracks 5

and 6, KBr extract fran Raji cells failed to serve as a cofactor for
factor I.

In contrast as shown in Figure 26, KBr extract from tonsil

cells as well

as

fl uid-phase C3b.
as

factor H resulted in cleavage of the
Sane cleavage of the

chain of

chain occurred in all cases

seen in Track 1 which sh<:MS the results of a 30 minute inucbation

of C3b alone.

Incubation of C3b with factors I, H or KBr extract from

tonsil cells resulted in
lustrated in Tracks 2,
the

a

a

a

chain

as

no

additional cleavage of the

4, and 5, respectively.

a

chain

as

il

Additional cleavage of

the result of the activity of factor H as a cofactor

for factor I is seen in Track 3.

Additional cleavage of the

a

chain
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Figure 25.

SDS-PAGE analysis of fluid-phase C3b.

C3b was incu

bated alone or with KBr extract fran Raji cells and/or C3b control
proteins.

All reaction mixtures contained C3b at 50 ug/ml in 0.04

ml of VBS.

In track 1, C3b

tor H (1 ug/ml).

was

incubated for 60 minutes with fac

In tracks 2 and 3, factor I

(6.25 ug/ml)

and fac

tor H (1 ug/ml) were incubated with C3b for 30 and 60 minutes, re
spectively.

In track 4, KBr extract (738 ug/ml) was incubated with

C3b alone for 60 minutes.

In tracks 5 and 6, KBr extract (738 ug/

ml) and factor I (6.25 ug/ml) were incubated with C3b for 30 and 60
minutes, respectively.
was

After incubation, suramin sodium at 1 mg/ml

added; samples were dialyzed overnight versus 0.0625 M Tris-HCl

and analyzed by SD5-PAGE on 10% acrylamide gels.
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Figure 26.

.

SDS-PAGE analysis of fluid-phase C3b.

C3b was incubat

ed alone or with KBr extract from tonsil cells and/or C3b control
proteins.

Concentrations of C3b, factor I and factor H were iden

tical to those described for Figure 25.
cells was tested at 625 ug/ml.

All incubations were for 30 minutes

at 37°C and samples were handled exactly
25.

In Track 1, C3b was incubated alone.

added.

KBr extract from tonsils

as

described for Figure
In Track 2, factor I was

In Track 3, factors I and H were added.

H was added.

In Track 5, KBr extract was added.

tor I and KBr extract were added.
tract were added.

In Track 4, factor
In Track 6, fac-

In Track 7, factor H and KBr ex
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by factor I in the presence of KBr extract from tonsil cells was also
de!lonstrated in Track 6.

The ability of KBr extract fran tonsil cells

to serve as a a:>factor for factor I in cleavage of fluid-phase C3b is
in contrast to its inability to serve as a a:>factor in the cleavage of
cell-bound C3b as determined
as

by inhibition of lysis.

Factor H serves

a rofactor for factor I for cleavage of both fluid-phase and cell

bound C3b.
Influence of KBr Extract fran Raji and Tonsil Cells on the Classical
Pathway
The previous observation that KBr extract from Raji cells in
hibited alternative pathway lysis prompted examination of its ability
to influence the classical pathway.

EAC4 were treated for 1 hour at

37°C with 18.75-150 ug/ml of extract, after which treated and untreat
ed EAC4 were used to quantitate arrounts of hemolytic Cl.

In experi

ment 1 of Table 14, KBr extract fran Raji cells shows a dose dependent
inhibition of lysis due to C1 which

by itself resulted in 92% lysis.

To approach possible mechanisms for this inhibition, an experiment was
performed in which an arrount of C1 resulting in 93% lysis was added to

EAC4 before or after treatment of EAC4 with KBr extract from Raji
cells.

In one case Cl was added to EAC4 and EAC14 were centr ifu g ed

p r i o r to addition o f KB r extract from Raji cells f o r 1 hour.

In the

other case, pretreatment of EAC4 with KBr extract for 1 hour with sub
sequent addition of Cl was also performed.
ment 2 of Table 14,

As can be seen in experi

prior addition of C1 to EAC4 before treatment with

KBr extract from Raji cells virtually eliminated previously observed
inhibition of subsequent lysis.

These results suggested the possibil-
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TABLE 14
INFLUENCE OF KBR EXTRACT FROM RAJ! CELLS ON Cl

Inhibition

(Z')

Extract u9/ml
E xperiment

2

150

75

3B

19

2.23

1.70

1.21

.39

2.20*

1.95

1.26

.65

.07

.04

.29**

•

15

*EAC4 were incubated with KBr extract from. Raji ce 11s for
hour and then incubated with 1.8 Z of Cl.
**EAC4 were incubated with 1.8 Z of Cl and then incubated with
KBr extract from Raji cells for 1 hour.
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ity that KBr extract from Raji cells had an effect on C4b similar to
that seen on C3b mich affected its function in the classical pathway

C3 convertase.

Tb address the possibility, �14 were treated with

VBS or KBr extract fran Raji cells at 600 ug/ml.

After 1 hour at 37

°

C, both untreated and treated �14 were used to quantitate human C2.

C2 titers were not altered by pretreatment of �4 with KBr extract
from Raji cells, changing from 4615 un its/ml (Z)

for untreated �14

to 3750 units/ml (Z) for �14 that had been treated with extract.
Similar arrounts of KBr extract from Raji cells had been shown to re
sult in over 90% inhibition of Cl activity.

It was concluded from

these series of experiments that KBr extract from Raji cells had lit
tle or no effect on the cla ssical pathway except for an effect on Cl.
Inhibition of Cl activity required the simulta neous presence of both
Cl and KBr extract.

One possible explanation for these results may be

the presence of the Clq receptor which is present on Raji cells and B
lymphocytes (Table 1).
KBr extract from Raji cells had been shown to have no detectable
influence on C2 decay from EAC142
tion).

(Daniel COnrad, personal conrnunica

KBr extract from tonsil cells was also tested for its influ

ence on the classical pathway convertase decay in the following exper
iment (Figure 27)

•

�142 were prepared which had approximately 2

sites of C2 per cell.

They were a llowed to decay in the presence of

VBS in 0.01 M EIYI2\/GVB or 604 ug/ml of KBr extract from tonsil cells
in 0.01 M ED'm/GVB.
as

°

After varying times at 30 C, rat senun was added

described in the Materials and Methods to detect lysis.

The half

life of the convertase in VBS was·S.S minutes; in KBr extract it de-
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Figure 27.

Influence of KBr extract from tonsil cells on decay of

classical pathway C3 convertase.
imately 2 z of C2/cell

(95% lysis)

EAC142 were prepared with approx
•

EAC142 were then incubated in

VBS with 0.01 M ED'ffi/GVB or KBr extract (604 ug/ml) in 0.01 M EDTA/
GVB for varying time periods at 30°C.
o-----o

VBS

.

------

KBr extract fran tonsil cells.
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clined to 7.8 minutes.

This is in oontrast to the reduction of the

alternative pathway convertase half-life (Table 9)

by 57% with only 5%

of the anount of extract used for the classical pathway convertase.
Although gp205 has been shown to cause decay of the classical pathway
convertase as well as the alternative pathway convertase, this experi
ment suggests that it is much less efficient in the classical pathway.
Influence of KBr Extract fran Raji and 'lbnsil Cells on Rosette
Formation with EAC43
Since the ability to inhibit formation of complement rosettes was
the original measure of C3b receptor function, KBr extracts fran both
Raji and tonsil cells were tested for their ability to inhibit ro
settes between Raji cells and EAC43 bearing both C3b and C3bi (Figure

28).

Both KBr extracts were found to inhibit rosette formation in a

dose dependent manner.

Surprisingly, ability of both KBr extracts to

inhibit rosettes between Raji cells and EAC43 bearing both C3b and
C3bi was unaffected by heat treatment whereas their effects in inhibi
tion of alternative pathway lysis was abrogated by the same treatment
(Figures 5 and 6).
Influence of KBr Extracts fran a Number of Raji Cell Lines on Rosette
Formation
The various Raji cell lines which had been tested earlier for
their ability to inhibit the alternative pathway (Table 3) were also
tested for their capacity to inhibit rosette formation.

It is clear

that although there are substantial differences in inhibition of al
ternative pathway lysis (Table 3), all cell lines clearly inhibit for
mation of rosettes as shown in Table 15.
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Figure 28.

Inhibition of rosettes by KBr extracts from

tonsil cells.
or at

56°C

Raji

or

KBr extract from Raji cells was preincubated at

prior to addition to EAC43.

0°C

KBr extract from tonsil

cells was preincubated at 0°C or at 60°C prior to addition to

EAC43.

Both were tested in separate experiments for inhibiti on of

rosettes as described in Materials.and Methods.
alone were 41 and 43% rosette positive,

Controls with VBS

respectively.

extract from Raji or tonsil oells preincubated at
extract from Raji cells preiocubated at 56°C.
from tonsil cells preincubated at

60°C.

0°C.

[s:sl KBr

0
[S3

KBr
KBr
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'mBLE 15
VARIABILI'IY IN RAJ! CELL LINES FOR
INHIBITION OF OOSEITES

Cell Line

% Inhibition of Rosettes

Raji CN old

62 .3

Raji CN new

25.3

Raji ATCX:

70.7

Raji Kumar

47.5

Raji MS

28.3

Raji OC old

56.5

Raji OC new

21.0

Inhibition of rosettes was performed in one experiment under
conditions described in Materials and Methods.
All values
are adjusted for an extract concentration of 1 mgjml.
Percent rosettes with buffer alone were 43% positive.
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Relationship of Inhibition of Rosettes due to KBr Extract fran Raji

and Tbnsil Cells with gp205
Since anti-gp205 has been shown to inhibit C3b-dependent rosette
formation on a number of cell types (67), its influence on inhibition
of rosettes due to KBr extracts fran both Raji and tonsil cells was of
interest.

Because gp205 is internalized by PMNs when it is cross

linked by antibody, KBr extract from both Raji and tonsil cells were
preincubated alone or with affinity purified anti-gp205

(Fab')2 on ice

for 30 minutes and subsequently centrif ug ed at 48,000 x G for 1 hour.
This step was included to prevent possible endocytosis of C3b receptor

by

excess anti-gp205.

After resuspension of pelleted membrane mater

ial in VBS, the residual ability of these extracts to inhibit C3b and
C3bi rosette formation with Raji cells was then tested.
lustrates the results of this experiment.

Figure 29 il

Preincubation with 156 ng

of anti-gp205 removed 65% of the inhibition of rosettes due to KBr ex
tract from tonsil cells, whereas it had no effect on the ability of
KBr extract fran Raji cells to inhibit rosettes.

The failure of anti

gp205 to remove inhibition of C3b and C3bi rosette fo rmation due to
KBr extract fran Raji cells suggests that membranes of Raji cells con
tain a component antigenically distinct from gp205 but which inhibits
formation of rosettes.

Earlier experiments had suggested that inhibi

tion of alternative pathway lysis and accelerated decay of EAC43bBb by
KBr extract from Raji cells were also not due solely to gp205
20, Table 13).

(Figure

Inhibition of C3b and C3bi dependent rosette fo rmation

due to KBr extract from tonsil cells is however due in part at least

to gp205 since pretreatment of KBr extract with anti-gp205 resulted in
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Figure 29.

Inhibition of rosettes by KBr extracts from Raji or

tonsil cells.

KBr extracts from Raji or tonsil cells were prein

cubated alone or with 156 ng/ml of anti-gp205 (Fab'J •
2
centrations of extract used are given in ug/ml.

Con

After centri

fugation and resuspension in VBS, all four were tested for inhi
bition of rosettes as described in Materials and Methods.
trols of_VBS alone were 45% rosette positive.
from Raji or tonsil cells alone.
tonsil cells with anti-gp205.
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a

reduction of inh ibition of 70%.

Earlier experiments had shown that

inhibition of alternative pathway lysis by KBr extract from tonsil
cells was completely removed by anti-gp205 and that accelerated decay
of �43bBb was also reduced by anti-gp205

(Figure 20, Table 13).
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DISC!JSSION

'lhese studies have examined the capacity of KBr extracts from a
number of cell types to inhibit alternative pathway lysis of
�43bBb.

TWo separate sources of Raji cells were positive, whereas

three other sources of Raji cells were negative for inhibition.

As

illustrated in Table 2, upon serial passage, both cell lines which
inhibited alternativ.e pathway lysis were subsequently negative.
reasons for this change are not clear.

The

'!he possibility that the ob

served variability among various Raji cell lines is due to differences in cell cycle seems unlikely for several reasons.

First, all

spinner flasks were established with cell concentrations of 1 x 105
per ml and cultured till the cell number was sanewhere between 1 x

109 to 2 x 109 per ml depending on the cell type.

Secondly, both

positive and negative extracts were prepared concurrently from two
different cell lines cultured in separate spinner flasks which were
begun at identical densities, terminated on the same day, and contained equivalent numbers of cells.

Lastly, the ability to inhibit

alternative pathway lysis was consistently found in the two positive
cell lines for long periods of time in over 15 individual membrane
preparations.
Previous experiments (Figure 12)

had shown that 1 mM FMSF had no

effect on the ability of KBr extracts from Raji and tonsil cells to
inhibit alternative pathway lysis.

Because of the failure to extract

active material from three Raji cell lines, an extract from one nega-
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tive cell line was prepared in the presence of 1 roM PMSF throughout
the entire procedure of cell d isruption, membrane ioolation, and
extraction (Figure 13).

The extract prepared in this manner still

failed to inhibit alternative pathway lysis.
other workers have observed variable expression of C3b recep
tors.

The expression of the C3b rec:ptor on FMNs depends on the dif

ferentiation state of the cell (89).

Also, the C3b receptor on B

lymphocytes is lost as the cell matures to a plasma cell (90).

Re

cently, Ryan, Schultz and Ryan have reported that both Fe and C3b
receptors are induced in bovine pulmonary endothelial cells by leu
kocyte lysates or infection with cytomegalovirus or influenza virus

(91)

•

Together, these reports suggest that a variety of cell types

are influenced both by differentiation state and influences of viral
infection or inflammatory stimuli on expression of the C3b receptor.
Since the Raji cell line has been in culture in many laboratories
since 1965,

it is not surprising that variability for a number of

characteristics reported for these cells should occur.
the serendipitous observation of an inhibitor(s)
man

In addition,

in both calf and hu

serum of inhibition of alternative pathway lysis due to KBr ex

tract fran Raji cells (Figures 17 and 19) demonstrates external in
fluences on the function and perhaps even the expression of the

mem

brane component responsible for inhibition.
Inhibition of alternative pathway lysis by KBr extracts from
Raji cells was dependent on both time and temperature of pretreatment
of �43 (Figure 7, Table 2).

These results provide evidence against

the possibility that the observed inhibition of lysis was due to an
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effect of extract on CS-c9, which oonstitute the terminal corrplement
oomponents responsible for hemolysis.

Although definitive studies

utilizing limiting ooncentratians of each of the terminal components
were not done, the dependence on time and temperature of pretreatment
of EAC43 for inhibition

by KBr extract from Raji cells supports a di

rect effect on C3b itself.
Since the C3b receptor an both human erythrocytes and PMNs is
trypsin sensitive

(28, 29), KBr extract from Raji cells was treated

with trypsin, pronase or protease.

These proteolytic treatments of

KBr extract from Raji cells were unsuccesful in eliminating inhibi
tion of alternative pathway lysis

(Figures 14 and 15).

The failure

of all of these enzymes to eliminate inhibition of lysis suggests two
possibilities.

The more obvious oonclusion is that inhibition of al

ternative pathway lysis is not due to a protein or glyooprotein which
is susceptible to cleavage by these enzymes.

Alternatively, the rel

ative insolubility of KBr extracts which have been dialyzed against

VBS may limit access of the enzymes to the extract, particularly with
enzymes oovalently bound to Sepharose.
KBr extracts from membranes of isolated mononuclear cells in
tonsils also inhibited alternative pathway lysis

(Figure 5).

This

result was expected since tonsils oontain a substantial percentage of

B lymphocytes and macrophages, previously shown by Fearon to possess
gp205 (67).

Inhibition of alternative pathway lysis was similar to

that. seen with KBr extracts from Raji cells.

Inhibition by both was

dependent on ooncentration of extract and was lost when extract was
heated· to 56 or 60 C before use.

In addition, inhibition of alter-
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native pathway lysis by KBr extract from tonsil cells was also sen
sitive to calf serum (Figure 18).

However, unlike the variation seen

with Raji cell lines, every preparation of KBr extract from tonsil
cells inhibited alternative pathway lysis.

The relationship of alternative pathway inhibition by KBr ex
tracts to gp205 was a central question in these studies.

Two inde

pendent sources of anti-gp205, a heteroantiserum and a monoclonal
antibody were used.

(Fab'l anti�205 from Dr. Douglas Fearon re
2

moved all inhibition of alternative pathway lysis by KBr extract from
tonsil cells, while 50% of inhibition by KBr extract from Raji cells
was retained (Figure 20) .

Similar results were obtained using a

monoclonal antibody from Drs. Gerdes and Stein (Figure 21) .

'!bus,

inhibition of alternative pathway lysis by KBr extract from Raji
cells, though similar to gp205 in other respects, was due at least in
part to a component antigenically distinct from gp205.
Another important question was the possible relationship of in
hibition of alternative pa�,way lysis by KBr extracts to either fac
tor H or I.

'!his was particularly relevant since Lambr is et al ( 41)

have reported the presence of endogenous factor I from both Raji
cells and normal B lymphocytes.

Adsorptions of KBr extracts from

both Raji and tonsil cells by antibodies to factor H and I conjugated
to Sepharose failed to remove the oomponent(s) in either extract re
sponsible for inhibition of alternative pathway lysis (Tables 4 and
5) .

'Ihese results are consistent with the report by Dobson et al,

since release of endogenous factor I required the interaction of fac
tor H with its receptor on the cell.
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The functional similarity of both KBr extracts to factor H was
also studied.

by

Factor H is essential for cleavage of fluid-phase C3b

factor I (21).

Fearon also showed that gp205 functions in a simi

lar manner with factor I.

In agreement with Fearon, KBr extract fran

tonsil cells served as a cofactor for factor I on cleavage of fluid
phase C3b (Figure 26).

However, KBr extract fran Raji cells failed

to serve as a cofactor for C3b cleavage (Figure 25).
of inhibition of alternative pathway lysis

by

Since about 50%

KBr extract fran Raji

cells was removed by anti-gp205, the failure of this extract to serve
as

a cofactor for factor I was sanewhat surprising although the con

centration of gp205 in the KBr extract from Raji cells may have been
In any case, the inability of KBr extract fran Raji cells

too low.

to function as a cofactor in cleavage of fluid-phase C3b provides ad
d itional evidence against endogenous factor H

as

the component in ex

tract responsible for inhibition of alternative pathway lysis, as
well

as

showing that the additional components which are not inhibit

ed by gp205 do not provide cofactor activity.
The role of factor H in regulation of the alternative pathway
was originally detected through its synergy with factor I on cell

bound C3b.

KBr extract fran Raji cells was tested for its ability to

synergize with factor I on cell-bound C3b.

Addition of KBr extract

to lCM amounts of factor I resulted in ooly an additive increase in
inhibition of hemolysis

(Daniel Oonrad,

personal communication)

•

An

analogous experiment using KBr extract from tonsil cells in the pres
ence of lCM concentratioos of factor I on cell-bound C3b was per
formed (Figure 24).

Unlike its effect on fluid-phase C3b in the
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presence.of factor I, KBr extract from tonsil cells resulted in only
additive inhibition of lysis due to limited cell-bound C3b.
ability of KBr extract from tonsil cells (gp205)

The

to serve as a co

factor for factor I in cleavage of fluid-phase C3b contrasts with its
fa ilure to serve as a cofactor for inactivation and presumed cleavage
of cell-bound C3b.

ed.

This observation has not been previously report

It may be significant in view of the postulated role for gp205

in adsorptive endocytosis.

It would be of interest to test the abil

ity of KBr extract from tonsil cells to serve as a cofactor for
cleavage of C3b on immune complexes, for example.
KBr extracts from both Raji and tonsil cells were examined for
their ability to accelerate decay of the alternative pathway C3 con
vertase, EAC43bBb.
gp205,

Since KBr extract from tonsil cells contained

it was expected that it would cause accelerated decay of the

alternative pathway C3 convertase.

Both extracts shortened the half

life of the convertase (Tables 7 and 8).

In the case of KBr extract
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from Raji cells, loss of
I factor B from the alternative pathway
convertase on zymosan was also demonstrated.
Previous work had shown that fluid-phase C3 and C3b inhibited
birrling of factor H to C3b (88).

Therefore, C3, C3b and C3bi were

tested for their ability to block the accelerated decay of the con
vertase due to both extracts.

Fluid- phase C3 was without effect on

accelerated decay b¥ either extract.

C3 did block accelerated decay

due to factor H (Table 9), which is consistent with its ability to
inhibit binding of factor H to cell-bound C3b.

Accelerated decay of

FJIC43bBb b¥ both factor H and KBr extract from tonsil cells was inhi-
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bited by fluid-phase C3b (Table 10)

•

Interaction of gp205 in KBr

extract fran tonsil cells with its ligand, C3b, might be expected to
remove the extract's ability to accelerate decay of �43b8b.
contrast to these results,

In

identical amounts of C3b were without

effect on the shortened half-life of the C3 convertase due to KBr ex
tract fran Raji cells.

These results are consistent with previous

experiments which implicated another corrponent distinct from gp205 in
Raji cells in inhibition of alternative pathway lysis.

Because Raji

cells are reported to bear receptors for C3bi, this C3 cleavage prod
uct was tested for its ability to block accelerated decay of the con
vertase by KBr extracts (Table 11).

Fluid-phase C3bi was without

effect on shortened half-life induced by either extract, while it in
hibited accelerated decay due to factor H.

The failure of C3bi to

inhibit accelerated decay by KBr extract from tonsil cells is consis
tent with the specificity of gp205 for C3b.

Its failure to inhibit

accelerated decay by KBr extract from Raji cells suggests that it is
oot the C3bi receptor on Raji cells which is involved in decay of the
C3 convertase.

One alternative which was not examined is the final

cleavage product of C3, which is C3d.

In addition to receptors for

C3bi, Raji cells also have receptors for C3d

(44).

As discussed earlier, treatment of KBr extracts with anti-gp205
completely removed inhibition of alternative pathway lysis by KBr ex
tract from tonsil cells while it removed ooly 50% of inhibition by
KBr extract from Raji cells.

Therefore,

its effect on accelerated

decay of �43b8b by both extracts was examined.

KBr extract from

tonsil cells shortened the half-life of the convertase from 8.8
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minutes to 3.8 minutes.

In the presence of 5 ug/ml of (Fab')
z

anti-gp205, KBr extract from tonsil cells did not appreciably alter
the half-life of the C3 convertase; 0.63 ug/ml of anti-gp205 had an
intermediate effect resulting in a half-life of 5.8 minutes.

These

results agree with previous reports on the activity of gp205 on decay
of EI\C3bBb.

The same amounts of anti-gp205 did not affect the short

ened half-life of FAC43bBb by KBr extract from Raji cells in a dose
dependent manner.

B oth shortened half-life of the alternative path

way C3 convertase ana inhibition of alternative pathway lysis by KBr
extract fran Raji cells differ from gp205 in similar extracts from
tonsil cells in their insensitivity to inhibition by anti-gp205 and
are presumbably due to an antigenically distinct rnolecule(s).
Although these studies were focused an the alternative pathway,
several experiments addressed potential effects of KBr extracts on
the classical pathway.

KBr extract from Raji cells was found to have

a pronounced effect on the activity of Cl when Cl and extract were
incubated with FAC4 before addition of C2 (Table 14).

Since inhibi

tion required the simultaneous presence of both Cl and extract, the
trivial explanation for these results is chelation of calcium by mem
brane fragments.

However, these results may also be due to the Clq

receptor on Raji cells (92).
Because of the similarity of the classical and alternative C 3
convertases,

the ability o f KB r extracts to accelerate decay of

FAC142 was examined.

KBr extract from Raji cells was unable to cause

accelerated decay of the classical pathway C3 convertase (Daniel
eairad, personal corrrnunicatian)

·•

KBr extract from tonsil cells was

138
tested -for its ability to shorten the half-life of the classical
pathway convertase (Figure 27).

The observed half-life in the pres

ence of extract did not differ from the control.

These results ap

pear to contradict those of Iiada and Nussenzweig (72) who showed
that gp205 accelerated decay of EAC142 as well as EAC3bBb.

However,

accelerated decay of the classical pathway convertase requires ap
proximately ten times_ as much gp205 .as is required for equivalent ac
Thus, the failure to see

celerated decay in the alternative pathway.
an

alteration in half-life of the classical pathway convertase by KBr

extract from tonsil cells is very likely due to an insufficient con
centration of gp205.

"Alternatively, differences in activity may be

due to the cell source used.
Inhibition of complement-dependent rosettes was the original
functional assay for complement receptors.

Dierich and Reisfield

shooed that· KBr solubilized membrane components from Raji cells inhi
bited complement-dependent rosettes (62).

Figure 28 confirms their

results using identical extracts from Raji cells.

KBr extracts from

tonsil cells also inhibited complement-dependent rosettes.

Previous

experirilents shCMed that incubation of both extracts at 57 or 60 C for
30 minutes eliminated their ability to inhibit alternative pathway
lysis.

However, extracts which had been heated retained their abili

ty to inhibit complement-dependent rosettes.

TO determine whether inhibition of rosettes by either extract
was due to gp205,

(Fab')

2

anti-gp205 was tested for its ability to

block inhibition of rosettes by both KBr extracts (Figure 29).

Anti

gp205 did remove a substantial amount of inhibition of rosettes by
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KBr extract from tonsil cells.

This result was expected since earli

er experiments had confirmed the presence of gp205 in these ex
tracts.

Anti-gp205 had no effect on inhibition of complement

dependent rosettes by KBr extract fran Raji cells.

These results

agree with earlier experiments in which KBr extract from Raji cells
retained its hemolytic effects in the presence of anti-gp205.
Several important questions have been raised by the results obtained in these studies.

The most obvious question remains the iden-

tity of the component(s) in KBr extract from Raji cells involved in
inhibition of alternative pathway lysis and accelerated decay of the
alternative pathway convertase.

It is clearly not gp205; the inabil-

ity of C3bi to inhibit its effect on half-life of the convertase sug
gests that it is not the C3bi receptor.

Use of C3d and/or antibody

to the C3d receptor would be informative about the possible role of
the C3d receptor on inhibition of alternative pathway activity.
Another useful series of experiments would include investigation
of the expression of the coq>onent in Raji cells involved in regula
tion of the alternative pathway.

Negative cell lines might be ex

posed to a number of factors which have been shown to increase ex
pression of complement receptors on epithelial cells by Ryan et al
(91), and on eosinophils by Anwar, Kay and their colleagues (93,
95, 96).

94,

The requ irement for substantial numbers of cells for ex

tract preparation might preclude such studies.

The ability to test

for expression of the component regulating complement activity uti
7
8
lizing 5 x 10
to 1 x 10
cells would be necessary.
The third area of investigation which these studies suggest is
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the ability of serum to eliminate effects of both Raji and tonsil
cells on regulation of alternative pathway lysis.
as

Gp205 is ten times

effective per m::>lecule as factor H in serum in causing decay of

the alternative pathway convertase.

(16, 23)

Limitation of its

influence to the cell surface bearing gp205 might be necessary to
insure plasma complement activation.
factor(s)

The presence in serum of a

preventing the fluid-phase function of gp205 would play an

important role.
possibility.

Further work will be required to address this
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Appendix I

A.

Stock solutions
Stock 1

5 X WS
85 grams NaCl
3.75 grams Na 5,5' diethyl barbital
5.75 grams 5,5' diethyl barbituric acid
pH 7.5
quantity suff icient (qs) to 2 liters

Stock 2

Isotonic ED� (0.086 M)
Dissolve 89.34 gm � in 1 liter of
distilled wa ter.
pH 7.5 with 0.3 M Sodium Hydroxide
qs to 2 liters

Stock 3

ws
200 m1 of Stock 1
qs to 1 liter

B.

Buff ers
200 ml of Stock 1 with 0.5 rrM M:]Cl 2 and
0.15 rrM C aCl2
qs to 1 liter
o5w++

2000 ml distilled H20 with 0.5 rrM MgCl 2
and 0.15 m M C aCl 2 and 100 gm of de xtrose

152

equal volumes of GVB* and 5 % dextrose
with 0.5 rrM MgCl 2 and 0.15 mM cac12
.01M

ED'm/
GVB

870 m1 Stock 1.
120 m1 Stock 2.
10 ml of 10% gelatin

04M

ED'm/
GVB

510 ml Stock 1 480 m1 Stock 2
10 ml of 10% gelatin

•

Mannitol/

GVB*

•

30 ml of 25% rnannitol in dis tilled water
20 ml of GVB*
volumes of .1M Na2HP04 and
.1M NaH 2P04 which give pH 6.0.

KI reagent

0.25 grn !2
8.3 grn KI in 100 ml 0.1M P0 4

Alsever's
solution

21.0 grn dextrose
8.0 grn sodium citrate
4.2 grn NaCl
0.4 grn citric acid (anhydrous)
pH 6-6.5
qs one liter.
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A£:pendix II
Reagent

Source

A

Dr. s. Ruddy

Anti-gp205

Dr. D. Fearon

(Fab')2
Anti-<::3
Receptor

Dr. H. Stein

Anti-IgE

Dr. D. Conrad

Cl

Dr. S. Ruddy

C2

Dr. S. Ruddy

C3

Dr. D. Conrad

C3b

Dr. H. Schenkein

C5

Dr. s. Ruddy

CNBr

Sigma Chemical, St. Iouis, MI

dextrose

Fisher Scientific, Pittsburgh, PA

factor B

Dr. S. Ruddy

factor D

Dr. S. Ruddy

factor H

Dr. S. Ruddy

factor I

Dr. S. Ruddy

FCS

GIBO), Grand Island, NY

Ficoll-Hypaque

Bionetics lab ., Kensington, MD

G-25

Pharmacia, P iscataway, NJ

gelatin

BBL Microbiol., Cockeysville, MD

HEPES
KBr

calbiochem, La Jolla, CA
Fisher Scientific, Pittsburgh, PA
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lactoperoxidase

Calbiochem, La Jolla Ca

mannitol

Dexter Corp., Chagrin Falls, OH

monoethanolamine

Fisher Scientific, Pittsburgh, PA

nitrocellulose
tubes

Beckmc:m Scientific, Silver Spring, MD

NaCl

Fisher Scientific, Pittsburgh, PA

Na 125I

New England Nuclear, Boston, MA

NBCS

GIBOJ, Grand Island, NY

NP-40

. Particle Data, Elmhurst, IL

p ronase

Sigma Chemical, St. Louis, MI

protease

Sigma Chemical, St. Louis, MI

rat serum

Pel-Freeze, Rogers, AK

R3

Dr. S. Ruddy

R345

Dr. S. Ruddy

RIM! 1640

GIBOJ, Grand Island, NY

SD5-PAGE
reagents

BioRad, Richmond, CA

SBTI

Sigma Chemical, St. Louis, MI

s-200

Pharmacia, Piscataway, NJ

5-300

Pharmac ia, Piscataway, NJ

Sephacryl Cl-4B

Pharmacia, Piscataway, NJ

Suramin sodium

FBA Pharmaceuticals, N.Y., NY

tissue culture
reagents

Bell=, Vineland, NJ

zymosan

Sigma Chemical, St. Louis, MI
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Model 250 Spectrophotometer

Gilford Instruments

Oberlin, OH

Automatic Garrrna
Scintillation Counter

Amersham-Searle Corp.

Des Plains ;

C0 2 Incubator

Forma Scientific

Marietta, OH

Series 2200 Computer

Wang Laboratories

Tewksbury, MA

IL

